Kemet (KEM) 10-Q 2 Feb 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2016	Jan. 30, 2017
Document and Entity Information
Entity Registrant Name	KEMET CORP
Entity Central Index Key	887,730
Document Type	10-Q
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		46,506,510
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Dec. 31, 2016	Mar. 31, 2016
Current assets:
Cash and cash equivalents	$ 87,356	$ 65,004
Accounts receivable, net	82,519	93,168
Inventories, net	154,519	168,879
Prepaid expenses and other	24,035	25,496
Total current assets	348,429	352,547
Noncurrent Assets:
Property, plant and equipment, net of accumulated depreciation of $817,605 and $815,338 as of December 31, 2016 and March 31, 2016, respectively	211,927	241,839
Goodwill	40,294	40,294
Intangible assets, net	30,204	33,301
Investment in NEC TOKIN	21,202	20,334
Deferred income taxes	7,768	8,397
Other assets	2,712	3,068
Total assets	662,536	699,780
Current liabilities:
Current portion of long-term debt	0	2,000
Accounts payable	62,347	70,981
Accrued expenses	46,418	50,320
Income taxes payable	1,068	453
Total current liabilities	109,833	123,754
Liabilities, Noncurrent [Abstract]
Long-term debt, less current portion	386,226	385,833
Other non-current obligations	72,704	74,892
Deferred income taxes	3,326	2,820
Stockholders’ equity:
Preferred stock, par value $0.01, authorized 10,000 shares, none issued	0	0
Common stock, par value $0.01, authorized 175,000 shares, issued 46,508 shares at December 31, 2016 and March 31, 2016	465	465
Additional paid-in capital	445,950	452,821
Retained deficit	(304,565)	(299,510)
Accumulated other comprehensive income	(51,024)	(31,425)
Treasury stock, at cost (67 and 611 shares at December 31, 2016 and March 31, 2016, respectively)	(379)	(9,870)
Total stockholders’ equity	90,447	112,481
Total liabilities and stockholders’ equity	$ 662,536	$ 699,780

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2016	Mar. 31, 2016
Property, Plant and Equipment, Net [Abstract]
Property and equipment, accumulated depreciation	$ 817,605	$ 815,338
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	0	0
Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Common stock, par value (in dollars per share)	$ 0.009998279866	$ 0.009998279866
Common stock, authorized shares	175,000,000	175,000,000
Common stock, issued shares	46,508,000	46,508,000
Treasury stock, shares	225,733	611,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Revenues [Abstract]
Net sales	$ 188,029		$ 177,184	$ 560,272	$ 550,897
Operating costs and expenses:
Cost of sales	140,692		138,436	423,999	429,630
Selling, general and administrative expenses	26,665		22,278	78,551	75,656
Research and development	7,059		6,134	21,107	18,560
Restructuring charges	(369)		1,714	4,317	3,561
Write down of long-lived assets	0	$ 6,200	0	6,193	0
Net (gain) loss on sales and disposals of assets	132		129	307	(233)
Total operating costs and expenses	174,179		168,691	534,474	527,174
Operating income (loss)	13,850		8,493	25,798	23,723
Non-operating (income) expense:
Interest income	(5)		(4)	(14)	(10)
Interest expense	9,918		9,852	29,751	29,676
Change in value of NEC TOKIN option	(6,900)		(700)	3,500	26,300
Other (income) expense, net	(3,384)		(1,320)	(6,683)	(2,495)
Income (loss) from before income taxes and equity income (loss) from NEC TOKIN	14,221		665	(756)	(29,748)
Income tax expense (benefit)	1,810		2,760	4,440	3,950
Income (loss) before equity income (loss) from NEC TOKIN	12,411		(2,095)	(5,196)	(33,698)
Equity income (loss) from NEC TOKIN	(133)		(6,505)	271	(4,758)
Net income (loss)	$ 12,278		$ (8,600)	$ (4,925)	$ (38,456)
Net income (loss) per basic share:
Net income (loss) per basic share (in usd per share)	$ 0.26		$ (0.19)	$ (0.11)	$ (0.84)
Net income (loss) per diluted share (in usd per share)	$ 0.22		$ (0.19)	$ (0.11)	$ (0.84)
Weighted-average shares outstanding:
Basic (in shares)	46,606		46,081	46,469	45,953
Diluted (in shares)	55,296		46,081	46,469	45,953

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 12,278	$ (8,600)	$ (4,925)	$ (38,456)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Foreign currency translation gains (losses)	(10,773)	(6,121)	(17,848)	(4,722)
Defined benefit pension plans, net of tax impact	165	6,910	492	7,322
Post-retirement plan adjustments	116	96	31	17
Equity interest in NEC TOKIN’s other comprehensive income (loss)	6,161	143	598	(4,463)
Foreign exchange contracts	(1,166)	672	(2,872)	(3,045)
Other comprehensive income (loss)	(5,497)	1,700	(19,599)	(4,891)
Total comprehensive income (loss)	$ 6,781	$ (6,900)	$ (24,524)	$ (43,347)

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Statement of Cash Flows [Abstract]
Net income (loss)	$ (4,925)	$ (38,456)
Operating Activities:
Depreciation and amortization	27,971	28,856
Equity (income) loss from NEC TOKIN	(271)	4,758
Non-cash debt and financing costs	561	649
Stock-based compensation expense	3,471	3,761
Receivable write down	64	24
Change in value of NEC TOKIN option	3,500	26,300
Net (gain) loss on sales and disposals of assets	307	(233)
Write down of long-lived assets	6,193	0
Pension and other post-retirement benefits	2,096	652
Change in deferred income taxes	819	735
Change in operating assets	21,459	4,762
Change in operating liabilities	(18,918)	(32,891)
Other	(183)	526
Net cash provided by (used in) operating activities	42,144	(557)
Investing activities:
Capital expenditures	(15,011)	(14,120)
Acquisitions, net of cash received	0	(2,892)
Proceeds from sale of assets	0	898
Net cash provided by (used in) investing activities	(15,011)	(16,114)
Financing activities:
Proceeds from revolving line of credit	0	10,000
Payments of revolving line of credit	0	(5,500)
Payments on long-term obligations	(2,428)	(481)
Proceeds from exercise of stock options	69
Purchase of treasury stock	(1,052)	(691)
Net cash provided by (used in) financing activities	(3,411)	3,328
Net increase (decrease) in cash and cash equivalents	23,722	(13,343)
Effect of foreign currency fluctuations on cash	(1,370)	139
Cash and cash equivalents at beginning of fiscal period	65,004	56,362
Cash and cash equivalents at end of fiscal period	$ 87,356	$ 43,158

Basis of Financial Statement Pr

Basis of Financial Statement Presentation	9 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Financial Statement Presentation	Basis of Financial Statement Presentation The condensed consolidated financial statements contained herein are unaudited and have been prepared from the books and records of KEMET Corporation and its subsidiaries (“KEMET” or the “Company”). In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. The condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q, and therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”). Although the Company believes the disclosures are adequate to make the information presented not misleading, it is suggested that these condensed consolidated financial statements be read in conjunction with the audited financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended March 31, 2016 (the “Company’s 2016 Annual Report”). The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. In consolidation, all significant intercompany amounts and transactions have been eliminated. Certain prior year amounts have been reclassified to conform to current year presentation. Net sales and operating results for the quarter and nine-month periods ended December 31, 2016 are not necessarily indicative of the results to be expected for the full year. The Company’s significant accounting policies are presented in the Company’s 2016 Annual Report. Use of Estimates and Assumptions The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and judgments based on historical data and other assumptions that management believes are reasonable. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period. The Company’s judgments are based on management’s assessment as to the effect certain estimates, assumptions, or future trends or events may have on the financial condition and results of operations reported in the unaudited condensed consolidated financial statements. It is important that readers of these unaudited financial statements understand that actual results could differ from these estimates, assumptions, and judgments. Recently Issued Accounting Pronouncements New accounting standards adopted/issued In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-16, Income Taxes - Intra-Entity Transfers of Assets Other Than Inventory. The update requires entities to recognize the income tax consequences of many intercompany asset transfers at the transaction date. The seller and buyer will immediately recognize the current and deferred income tax consequences of an intercompany transfer of an asset other than inventory. The tax consequences were previously deferred. The effective date of this update is for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The update requires modified retrospective transition method which is a cumulative effect adjustment to retained earnings as of the beginning of the first effective reporting period. The Company is currently evaluating the impact of the adoption of this guidance on the Company’s consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The update clarifies how cash receipts and cash payments in certain transactions are presented and classified in the statement of cash flows. The effective date of this update is for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The update requires retrospective application to all periods presented but may be applied prospectively if retrospective application is impracticable. The Company is currently evaluating the impact of the adoption of this guidance on the Company’s consolidated financial statements. In March 2016, the FASB issued ASU No. 2016-09, Compensation-Stock Compensation. This guidance changes several aspects of the accounting for share-based payment award transactions, including: (1) Accounting and Cash Flow Classification for Excess Tax Benefits and Deficiencies, (2) Forfeitures, and (3) Tax Withholding Requirements and Cash Flow Classification. This ASU is effective for fiscal years and interim periods within those years beginning after December 15, 2016. Early application is permitted, and KEMET adopted ASU No. 2016-09 as of April 1, 2016. The Company elected to discontinue estimating forfeitures that are expected to occur and recorded a cumulative effect adjustment to retained earnings of $130,000 as of April 1, 2016. There was no cumulative adjustment related to the excess tax benefits as the Company did not have an additional paid in capital pool of excess tax benefits. The adoption did not have a significant impact on the Company’s consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases. The ASU requires lessees to recognize a right-of-use asset and a lease liability for virtually all of their leases (other than short-term leases). The guidance is to be applied using a modified retrospective approach at the beginning of the earliest comparative period in the financial statements. This ASU is effective for fiscal years and interim periods within those years beginning after December 15, 2018. Early application is permitted. The Company is currently in the process of assessing the impact the adoption of this guidance will have on the Company’s consolidated financial statements. In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory. The ASU requires an entity that uses first-in, first-out or average cost to measure its inventory at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. ASU 2015-11 was effective for interim and annual reporting periods beginning April 1, 2016. The adoption of ASU 2015-11 did not materially impact the Company’s operating results and financial position. In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The ASU specifies that debt issuance costs related to a note shall be reported in the balance sheet as a direct reduction from the face amount of the note. In August 2015, the FASB issued ASU No. 2015-15, Interest - Imputation of Interest (Subtopic 835-30) - Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements, which clarifies the treatment of debt issuance costs associated with line-of-credit arrangements that were not specifically addressed in ASU 2015-03. ASU 2015-15 states that entities may elect to continue to treat debt issuance costs associated with lines of credit as an asset, consistent with current treatment. The Company adopted these ASUs in the first quarter of fiscal year 2017. The ASUs did not impact the Company’s results of operations or liquidity. The balance sheet as of March 31, 2016 has been adjusted to reflect retrospective application of the new accounting guidance as follows (amounts in thousands): As Previously Reported Retrospective Adjustment As Adjusted Other assets $ 5,832 $ (2,764 ) $ 3,068 Total assets 702,544 (2,764 ) 699,780 Long-term debt, less current portion 388,597 (2,764 ) 385,833 Total liabilities and stockholders’ equity 702,544 (2,764 ) 699,780 In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern. The new guidance requires management to assess if there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim period. If conditions or events give rise to substantial doubt, disclosures are required. ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual and interim periods thereafter; early application is permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which supersedes existing accounting standards for revenue recognition and creates a single framework. The new guidance requires either a retrospective or a modified retrospective approach at adoption. Additional updates to Topic 606 issued by the FASB in 2015 and 2016 include the following: • ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which defers the effective date of the new guidance such that the new provisions will now be required for fiscal years, and interim periods within those years, beginning after December 15, 2017 (ASU No. 2015-14 is effective for the Company’s fiscal year that begins on April 1, 2018 and interim periods within that fiscal year). • ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, which clarifies the implementation guidance on principal versus agent considerations (reporting revenue gross versus net). • ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which clarifies the implementation guidance on identifying performance obligations and classifying licensing arrangements. • ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which clarifies the implementation guidance in a number of other areas. • ASU No. 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. The effective date of this guidance is for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted , but not before the Company’s fiscal year that begins on April 1, 2017 (the original effective date of the ASU). The Company plans to adopt the requirements of the new standard in the first quarter of fiscal year 2019. The Company is currently in the process of assessing the impact the adoption of the new revenue standards will have on its consolidated financial statements and related disclosures. There are currently no other accounting standards that have been issued that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption. Fair Value Measurement The Company utilizes three levels of inputs to measure the fair value of (a) nonfinancial assets and liabilities that are recognized or disclosed at fair value in the Company’s consolidated financial statements on a recurring basis (at least annually) and (b) all financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The first two inputs are considered observable and the last is considered unobservable. The levels of inputs are as follows: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Assets and liabilities measured at fair value on a recurring basis as of December 31, 2016 and March 31, 2016 are as follows (amounts in thousands): Carrying Value December 31, Fair Value December 31, Fair Value Measurement Using Carrying Value March 31, Fair Value March 31, Fair Value Measurement Using 2016 2016 Level 1 Level 2 (2) Level 3 2016 2016 Level 1 Level 2 (2) Level 3 Assets (Liabilities): Money markets (1) $ 719 $ 719 $ 719 $ — $ — $ 738 $ 738 $ 738 $ — $ — Total debt (386,226 ) (383,880 ) (353,441 ) (30,439 ) — (387,833 ) (284,261 ) (254,713 ) (29,548 ) — NEC TOKIN option, net (3) (24,100 ) (24,100 ) — — (24,100 ) (20,600 ) (20,600 ) — — (20,600 ) ___________________ (1) Included in the line item “Cash and cash equivalents” on the Condensed Consolidated Balance Sheets. (2) The valuation approach used to calculate fair value was a discounted cash flow based on the borrowing rate for each respective debt facility. (3) See Note 6 , “Investment in NEC TOKIN,” for a description of the NEC TOKIN option. The value of the option depends on the enterprise value of NEC TOKIN Corporation and its forecasted EBITDA over the duration of the option. The option has been valued using option pricing methods in a Monte Carlo simulation. The table below summarizes NEC TOKIN option valuation activity using significant unobservable inputs (Level 3) (amounts in thousands): March 31, 2016 $ (20,600 ) Change in value of NEC TOKIN option (3,500 ) December 31, 2016 $ (24,100 ) Inventories Inventories are stated at the lower of cost or market. The components of inventories are as follows (amounts in thousands): December 31, 2016 March 31, 2016 Raw materials and supplies $ 68,233 $ 80,289 Work in process 48,545 46,631 Finished goods 53,709 58,060 170,487 184,980 Inventory reserves (15,968 ) (16,101 ) $ 154,519 $ 168,879 Warrant As of December 31, 2016 and March 31, 2016 , 8.4 million shares were subject to the warrant (which expires June 30, 2019) held by K Equity, LLC. Revenue Recognition The Company ships products to customers based upon firm orders and revenue is recognized when the sales process is complete. This occurs when products are shipped to the customer in accordance with the terms of an agreement of sale, there is a fixed or determinable selling price, title and risk of loss have been transferred and collectability is reasonably assured. Based on product availability, customer requirements and customer consent, the Company may ship products earlier than the initial planned ship date. Shipping and handling costs are included in cost of sales. A portion of sales is related to products designed to meet customer specific requirements. These products typically have stricter tolerances making them useful to the specific customer requesting the product and to customers with similar or less stringent requirements. The Company recognizes revenue when title to the products transfers to the customer. A portion of sales is made to distributors under agreements allowing certain rights of return and price protection on unsold merchandise held by distributors. The Company’s distributor policy includes inventory price protection and “ship-from-stock and debit” (“SFSD”) programs common in the industry. KEMET’s SFSD program provides authorized distributors with the flexibility to meet marketplace prices by allowing them, upon a pre-approved case-by-case basis, to adjust their purchased inventory cost to correspond with current market demand. Requests for SFSD adjustments are considered on an individual basis, require a pre-approved cost adjustment quote from their local KEMET sales representative and apply only to a specific customer, part, specified special price amount, specified quantity, and are only valid for a specific period of time. To estimate potential SFSD adjustments corresponding with current period sales, KEMET records a sales reserve based on historical SFSD credits, distributor inventory levels, and certain accounting assumptions, all of which are reviewed quarterly. Most of the Company’s distributors have the right to return to KEMET a certain portion of the purchased inventory, which, in general, does not exceed 6% of their purchases from the previous fiscal quarter. KEMET estimates future returns based on historical return patterns and records a corresponding allowance on the Condensed Consolidated Balance Sheets. The Company also offers volume based rebates on a case-by-case basis to certain customers in each of the Company’s sales channels. The establishment of sales allowances is recognized as a component of the line item “Net sales” on the Condensed Consolidated Statements of Operations, while the associated reserves are included in the line item “Accounts receivable, net” on the Condensed Consolidated Balance Sheets. Estimates used in determining sales allowances are subject to various factors. This includes, but is not limited to, changes in economic conditions, pricing changes, product demand, inventory levels in the supply chain, the effects of technological change, and other variables that might result in changes to the Company’s estimates. The Company provides a limited warranty to customers that the Company’s products meet certain specifications. The warranty period is generally limited to one year , and the Company’s liability under the warranty is generally limited to a replacement of the product or refund of the purchase price of the product. Warranty costs as a percentage of net sales were less than 1.0% for the quarters and nine-month periods ended December 31, 2016 and 2015 . The Company recognizes warranty costs when they are both probable and reasonably estimable.

Debt

Debt	9 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Debt	Debt A summary of debt is as follows (amounts in thousands): December 31, March 31, 10.5% Senior Notes, net (1) $ 352,345 $ 353,952 Revolving line of credit 33,881 33,881 Total debt 386,226 387,833 Current maturities — (2,000 ) Total long-term debt $ 386,226 $ 385,833 (1) As noted in Note 1, “Basis of Financial Statements Presentation,” ASU No. 2015-03, Interest - Imputation of Interest, was adopted as of April 1, 2016. As such, debt issuance cost, if any, is included within the respective debt balance. Amounts shown are net of premium and debt issuance costs of $0.7 million and $1.0 million as of December 31, 2016 and March 31, 2016 , respectively which reduce the 10.5% Senior Notes balance. The line item “Interest expense” on the Condensed Consolidated Statements of Operations for the quarters and nine-month periods ended December 31, 2016 and 2015 , consists of the following (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Contractual interest expense $ 9,693 $ 9,761 $ 29,091 $ 29,332 Capitalized interest (48 ) (163 ) (151 ) (439 ) Amortization of debt issuance costs 348 348 1,044 1,044 Amortization of debt (premium) discount (204 ) (188 ) (603 ) (554 ) Imputed interest on acquisition-related obligations 39 52 120 159 Interest expense on capital lease 90 42 250 134 Total interest expense $ 9,918 $ 9,852 $ 29,751 $ 29,676 Revolving Line of Credit On May 2, 2016, the Loan and Security Agreement dated September 30, 2010, as amended, by and among KEMET Electronics Corporation (“KEC”), KEMET Electronics Marketing (S) Pte. Ltd., KEMET Foil Manufacturing, LLC (“KEMET Foil”), KEMET Blue Powder Corporation (“KEMET Blue Powder”), The Forest Electric Company and the financial institutions party thereto (the “Loan and Security Agreement”), was amended and, as a result, the revolving credit facility increased to $65.0 million . The Company had the following activity for the nine-month period ended December 31, 2016 and resulting balances under the revolving line of credit (amounts in thousands, excluding percentages): March 31, Nine-Month Period Ended December 31, 2016 December 31, Outstanding Borrowings Additional Borrowings Repayments Outstanding Borrowings Rate (1) (2) Due Date U.S. Facility $ 19,881 $ — $ — $ 19,881 5.000 % December 19, 2019 Singapore Facility Singapore Borrowing 1 (3) 12,000 — — 12,000 3.500 % February 21, 2017 Singapore Borrowing 2 (3)(4) 2,000 — — 2,000 3.375 % January 9, 2017 Total Facilities $ 33,881 $ — $ — $ 33,881 ______________________________________________________________________________ (1) For U.S. borrowings, Base Rate plus 1.50% , as defined in the Loan and Security Agreement. (2) For Singapore borrowings, London Interbank Offer Rate (“LIBOR”), plus a spread of 2.50% as of December 31, 2016 . (3) The Company has the intent and ability to extend the due date on the Singapore borrowings. (4) In January 2017, the Company extended the due date to April 10, 2017 at 3.625% . As of December 31, 2016 , these were the only borrowings under the revolving line of credit, and the Company’s available borrowing capacity under the Loan and Security Agreement was $31.1 million . 10.5% Senior Notes On May 10, 2016, the Company repurchased and retired $2.0 million of its 10.5% Senior Notes due May 1, 2018 (the “ 10.5% Senior Notes”). As of December 31, 2016 and March 31, 2016 , the Company had outstanding $353.0 million and $355.0 million , respectively in aggregate principal amount of the Company’s 10.5% Senior Notes. The Company had interest payable related to the 10.5% Senior Notes included in the line item “Accrued expenses” on its Condensed Consolidated balance sheets of $6.2 million and $15.5 million as of December 31, 2016 and March 31, 2016 , respectively.

Impairment charges

Impairment charges	9 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Impairment charges	Impairment Charges In the quarter ended September 30, 2016 we recorded a write down of long-lived assets of $6.2 million due to the following two actions. On August 31, 2016, KEMET Electronics Corporation, a wholly-owned subsidiary of KEMET made the decision to shut-down operations of its wholly-owned subsidiary, KEMET Foil Manufacturing, LLC (“KFM”). Operations at KFM’s Knoxville, Tennessee plant ceased as of October 31, 2016. KFM supplied formed foil to the Company’s Film and Electrolytic Business Group (“Film and Electrolytic”), as well as to certain third party customers. The Company anticipates that Film and Electrolytic will achieve raw material cost savings by purchasing its formed foil from suppliers that have the advantage of lower utility costs. During the second fiscal quarter ending September 30, 2016, Film and Electrolytic recorded impairment charges totaling $4.1 million comprised of $3.0 million for the write down of property plant and equipment and $1.1 million for the write down of intangible assets. The impairment charges are recorded on the Condensed Consolidated Statements of Operations line item “Write down of long-lived assets”. In addition, the Company has accrued severance charges and restructuring costs described in Note 4 , “Restructuring Charges.” Due to the operating loss incurred by Film and Electrolytic in the nine-month period ending December 31, 2016, we tested its long-lived assets for impairment as of December 31, 2016 and concluded that the long-lived assets for Film and Electrolytic were not impaired. The Solid Capacitor Business Group (“Solid Capacitors”) initiated a plan to relocate its K-Salt operations from a leased facility to its existing Matamoros, Mexico facility. Impairment charges of approximately $2.1 million are recorded on the Condensed Consolidated Statements of Operations line item “Write down of long-lived assets”. In addition, the Company has accrued severance charges described in Note 4 , “Restructuring Charges” and has incurred equipment relocation costs of approximately $0.1 million in the third quarter of fiscal year 2017 and expects to incur an additional $1.1 million through June of 2017.

Restructuring Charges

Restructuring Charges	9 Months Ended
	Dec. 31, 2016
Restructuring and Related Activities [Abstract]
Restructuring Charges	Restructuring Charges KEMET’s restructuring plans are focused on making the Company more competitive by reducing excess capacity, relocating production to lower cost locations and eliminating unnecessary costs throughout the Company. A summary of the expenses aggregated in the Condensed Consolidated Statements of Operations line item “Restructuring charges” in the quarters and nine-month periods ended December 31, 2016 and 2015 , is as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Personnel reduction costs $ (215 ) $ 795 $ 1,864 $ 1,905 Relocation and exit costs (154 ) 919 2,453 1,656 Restructuring charges $ (369 ) $ 1,714 $ 4,317 $ 3,561 Quarter Ended December 31, 2016 The Company recorded a credit of $0.4 million in restructuring charges in the quarter ended December 31, 2016 comprised of a $0.2 million credit to personnel reduction costs and a $0.2 million credit to manufacturing relocation and exit costs. The credit to personnel reduction costs of $0.2 million is due to natural attrition in Matamoros, Mexico resulting in a reduction in severance accrual. The credit to manufacturing relocation costs of $0.2 million primarily consists of a $0.3 million reduction in accrual related to contract termination costs related to the shut-down of operations for KFM partially offset by the following charges: $0.1 million related to transfers of Film and Electrolytic production lines and R&D functions to lower cost regions and $0.1 million in expenses related to the relocation of the K-Salt operations to the existing Matamoros, Mexico plant . Nine-Month Period Ended December 31, 2016 The Company incurred $4.3 million in restructuring charges in the nine-month period ended December 31, 2016 comprised of $1.9 million in personnel reduction costs and $2.5 million in manufacturing relocation and exit costs. The personnel reduction costs of $1.9 million consist of $0.4 million in headcount reductions related to the shut-down of operations for KFM in Knoxville, Tennessee , $0.3 million related to the consolidation of certain Solid Capacitor manufacturing in Matamoros, Mexico , $0.3 million for overhead reductions in Sweden , $0.3 million in U.S. headcount reductions related to the relocation of global marketing functions to the Company’s Fort Lauderdale, Florida office , $0.3 million related to headcount reductions in Europe (primarily Italy and Landsberg, Germany) corresponding with the relocation of certain production lines and laboratories to lower cost regions , $0.2 million overhead reductions as we relocate the R&D operations from Weymouth, England to Evora, Portugal , and $0.1 million in manufacturing headcount reductions related to the relocation of the K-Salt operations to the existing Matamoros, Mexico plant. The manufacturing relocation costs of $2.5 million primarily consists of $1.9 million in expenses related to contract termination costs related to the shut-down of operations for KFM , $0.4 million related to transfers of Film and Electrolytic production lines and R&D functions to lower cost regions , $0.1 million related to the transfer of certain Tantalum production from Simpsonville, South Carolina to Victoria, Mexico , and $0.1 million in expenses related to the relocation of the K-Salt operations to the existing Matamoros, Mexico plant . Quarter Ended December 31, 2015 The Company incurred $1.7 million in restructuring charges in the quarter ended December 31, 2015 including $0.8 million in personnel reduction costs and $0.9 million in manufacturing relocation costs. The personnel reduction costs of $0.8 million were due primarily to $0.5 million related to the consolidation of certain Solid Capacitor manufacturing in Victoria, Mexico , $0.1 million for headcount reductions in Matamoros, Mexico related to the relocation of certain Solid Capacitor manufacturing from Matamoros, Mexico to Victoria, Mexico , and $0.1 million for overhead reductions in North America and Europe . The Company also incurred $0.9 million of manufacturing relocation costs for transfers of Film and Electrolytic production lines to lower cost regions. Nine-Month Period Ended December 31, 2015 The Company incurred $3.6 million in restructuring charges in the nine-month period ended December 31, 2015 comprised of $1.9 million of personnel reduction costs and $1.7 million in manufacturing relocation costs. The personnel reduction costs of $1.9 million consist of the following: $0.9 million for headcount reductions in Matamoros, Mexico related to the relocation of certain Solid Capacitor manufacturing from Matamoros, Mexico to Victoria, Mexico , $0.6 million related to a headcount reduction in Suzhou, China for the Film and Electrolytic production line transfer from Suzhou, China to Anting, China , $0.5 million related to the consolidation of certain Solid Capacitor manufacturing in Victoria, Mexico , $0.4 million for headcount reductions in Europe (primarily Landsberg, Germany) and $0.6 million for headcount reductions related to the outsourcing of the Company’s information technology function and overhead reductions in North America and Europe . These personnel reduction costs were partially offset by a $1.2 million reversal of a severance accrual in Italy. The Company originally recorded the accrual in the third quarter of fiscal year 2015 corresponding with a plan to reduce headcount by 50 employees. Under the plan, 24 employees were terminated. However, due to unexpected workforce attrition combined with achieving other cost reduction goals, the Company decided not to complete the remaining headcount reduction. Consequently, the Company reversed the remaining accrual during the second quarter of fiscal year 2016. The Company also incurred $1.7 million of manufacturing relocation costs for transfers of Film and Electrolytic production lines to lower cost regions. Reconciliation of Restructuring Liability A reconciliation of the beginning and ending liability balances for restructuring charges included in the line items “Accrued expenses” and “Other non-current obligations” on the Condensed Consolidated Balance Sheets for the quarters and nine-month periods ended December 31, 2016 and 2015 is as follows (amounts in thousands): Quarter Ended December 31, 2016 Quarter Ended December 31, 2015 Personnel Reductions Manufacturing Relocations Personnel Reductions Manufacturing Relocations Beginning of period $ 2,101 $ 1,982 $ 2,279 $ — Costs charged to expense (215 ) (154 ) 795 919 Costs paid or settled (579 ) (832 ) (1,209 ) (919 ) Change in foreign exchange (46 ) — (43 ) — End of period $ 1,261 $ 996 $ 1,822 $ — Nine-Month Period Ended December 31, 2016 Nine-Month Period Ended December 31, 2015 Personnel Reductions Manufacturing Relocations Personnel Reductions Manufacturing Relocations Beginning of period $ 976 $ — $ 7,239 $ — Costs charged to expense 1,864 2,453 1,905 1,656 Costs paid or settled (1,510 ) (1,457 ) (7,492 ) (1,656 ) Change in foreign exchange (69 ) — 170 — End of period $ 1,261 $ 996 $ 1,822 $ —

Comprehensive Income (Loss) and

Comprehensive Income (Loss) and Accumulated Other Comprehensive Income	9 Months Ended
	Dec. 31, 2016
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Comprehensive Income (Loss) and Accumulated Other Comprehensive Income	Comprehensive Income (Loss) and Accumulated Other Comprehensive Income Changes in Accumulated Other Comprehensive Income (Loss) (“AOCI”) for the quarters ended December 31, 2016 and 2015 include the following components (amounts in thousands): Foreign Currency Translation (1) Post-Retirement Defined Benefit Pension Plans, Net of Tax (2) Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) Foreign Exchange Contracts Net Accumulated Other Comprehensive Income (Loss) Balance at September 30, 2016 $ (17,347 ) $ 1,029 $ (14,834 ) $ (12,302 ) $ (2,073 ) $ (45,527 ) Other comprehensive income (loss) before reclassifications (10,773 ) — — 6,161 (2,146 ) (6,758 ) Amounts reclassified out of AOCI — 116 165 — 980 1,261 Other comprehensive income (loss) (10,773 ) 116 165 6,161 (1,166 ) (5,497 ) Balance at December 31, 2016 $ (28,120 ) $ 1,145 $ (14,669 ) $ (6,141 ) $ (3,239 ) $ (51,024 ) Foreign Currency Translation (1) Post-Retirement Defined Benefit Pension Plans, Net of Tax (2) Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) Foreign Exchange Contracts Net Accumulated Other Comprehensive Income (Loss) Balance at September 30, 2015 $ (10,733 ) $ 1,080 $ (19,951 ) $ (3,069 ) $ (2,714 ) $ (35,387 ) Other comprehensive income (loss) before reclassifications (6,121 ) — 6,663 143 (1,096 ) (411 ) Amounts reclassified out of AOCI — 96 247 — 1,768 2,111 Other comprehensive income (loss) (6,121 ) 96 6,910 143 672 1,700 Balance at December 31, 2015 $ (16,854 ) $ 1,176 $ (13,041 ) $ (2,926 ) $ (2,042 ) $ (33,687 ) Changes in AOCI for the nine-month periods ended December 31, 2016 and 2015 include the following components (amounts in thousands): Foreign Currency Translation (1) Post-Retirement Defined Benefit Pension Plans, Net of Tax (2) Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) Foreign Exchange Contracts Net Accumulated Other Comprehensive Income (Loss) Balance at March 31, 2016 $ (10,272 ) $ 1,114 $ (15,161 ) $ (6,739 ) $ (367 ) $ (31,425 ) Other comprehensive income (loss) before reclassifications (17,848 ) — — 598 (6,745 ) (23,995 ) Amounts reclassified out of AOCI — 31 492 — 3,873 4,396 Other comprehensive income (loss) (17,848 ) 31 492 598 (2,872 ) (19,599 ) Balance at December 31, 2016 $ (28,120 ) $ 1,145 $ (14,669 ) $ (6,141 ) $ (3,239 ) $ (51,024 ) Foreign Currency Translation (1) Post-Retirement Defined Benefit Pension Plans, Net of Tax (2) Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) Foreign Exchange Contracts Net Accumulated Other Comprehensive Income (Loss) Balance at March 31, 2015 $ (12,132 ) $ 1,159 $ (20,363 ) $ 1,537 $ 1,003 $ (28,796 ) Other comprehensive income (loss) before reclassifications (4,722 ) — 6,663 (4,463 ) (6,289 ) (8,811 ) Amounts reclassified out of AOCI — 17 659 — 3,244 3,920 Other comprehensive income (loss) (4,722 ) 17 7,322 (4,463 ) (3,045 ) (4,891 ) Balance at December 31, 2015 $ (16,854 ) $ 1,176 $ (13,041 ) $ (2,926 ) $ (2,042 ) $ (33,687 ) (1) Due primarily to the Company’s valuation allowance on deferred tax assets, there were no significant deferred tax effects associated with the cumulative currency translation gains and losses during the quarter and nine-month periods ended December 31, 2016 and 2015 . (2) Ending balance is net of tax of $2.0 million and $2.2 million as of December 31, 2016 and December 31, 2015 , respectively.

Investment in NEC TOKIN

Investment in NEC TOKIN	9 Months Ended
	Dec. 31, 2016
Equity Method Investments and Joint Ventures [Abstract]
Investment in NEC TOKIN	Investment in NEC TOKIN On March 12, 2012, KEC, a wholly owned subsidiary of the Company, entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with NEC TOKIN Corporation (“NEC TOKIN”), a manufacturer of tantalum capacitors, electro-magnetic, electro-mechanical and access devices, to acquire 51% of the common stock of NEC TOKIN (which represented a 34% economic interest, as calculated based on the number of common shares held by KEC, directly and indirectly, in proportion to the aggregate number of outstanding common and convertible preferred shares of NEC TOKIN as of such date) (the “Initial Purchase”) from NEC Corporation (“NEC”) of Japan. The transaction closed on February 1, 2013, at which time KEC paid a purchase price of $50.0 million for new shares of common stock of NEC TOKIN (the “Initial Closing”). The Company accounts for its investment in NEC TOKIN using the equity method for a non-consolidated variable interest entity since KEC does not have the power to direct significant activities of NEC TOKIN. The Company believes that the NEC TOKIN convertible preferred stock represents in-substance common stock of NEC TOKIN and, as a result, its method of calculating KEC’s economic basis in NEC TOKIN is the appropriate basis on which to recognize its share of the earnings or loss of NEC TOKIN. In connection with KEC’s execution of the Stock Purchase Agreement, KEC entered into a Stockholders’ Agreement (the “Stockholders’ Agreement”) with NEC TOKIN and NEC, which provides for restrictions on transfers of NEC TOKIN’s capital stock, certain tag-along and first refusal rights on transfer, restrictions on NEC’s ability to convert the preferred stock of NEC TOKIN held by it, certain management services to be provided to NEC TOKIN by KEC (or an affiliate of KEC) and certain board representation rights. KEC holds four of seven NEC TOKIN director positions. However, NEC has significant board rights. Concurrent with execution of the Stock Purchase Agreement and the Stockholders’ Agreement, KEC entered into an Option Agreement (the “Option Agreement”) with NEC, which was amended on August 29, 2014, whereby KEC had the right to purchase additional shares of NEC TOKIN common stock from NEC TOKIN for a purchase price of $50.0 million resulting in an economic interest of approximately 49% while maintaining ownership of 51% of NEC TOKIN’s common stock (the “First Call Option”) by providing notice of the First Call Option between the Initial Closing and April 30, 2015. Upon providing such First Call Option notice, but not before April 1, 2015, KEC could also have exercised a second option to purchase all outstanding capital stock of NEC TOKIN from its stockholders, primarily NEC, for a purchase price based on the greater of six times LTM EBITDA (as defined in the Option Agreement) less the previous payments and certain other adjustments, or the outstanding amount of NEC TOKIN’s debt obligation to NEC (the “Second Call Option”) by providing notice of the Second Call Option by May 31, 2018. The First and Second Call Options expired on April 30, 2015 without being exercised. Through May 31, 2018, NEC may require KEC to purchase all outstanding capital stock of NEC TOKIN from its stockholders, primarily NEC (the “Put Option”), provided that KEC’s payment of the Put Option price is permitted under the 10.5% Senior Notes and Loan and Security Agreement. However, in the event that KEC issues new debt securities principally to refinance its outstanding 10.5% Senior Notes due 2018 and its currently outstanding credit agreement, including amounts to pay related fees and expenses and to use for general corporate purposes (“Refinancing Notes”), prior to NEC’s delivery of its notification of exercise of the Put Option, then the earliest date NEC may exercise the Put Option is automatically extended to the day immediately following the final scheduled maturity date of such Refinancing Notes, or in the event such Refinancing Notes are redeemed in full prior to such final scheduled maturity date, then on the day immediately following the date of such full redemption, but in any event beginning no later than November 1, 2019. If not previously exercised, the Put Option will expire on October 31, 2023. The purchase price for the Put Option will be based on the greater of six times LTM EBITDA less previous payments and certain other adjustments, or the outstanding amount of NEC TOKIN’s debt obligation to NEC as of the date the Put Option is exercised. The purchase price for the Put Option is reduced by the amount of NEC TOKIN’s debt obligation to NEC which KEC will assume. The determination of the purchase price could be modified in the event there is a disagreement between NEC and KEC under the Stockholders’ Agreement. The Company has marked the Put Option to fair value and in the quarter and nine-month periods ended December 31, 2016 recognized a $6.9 million gain and a $3.5 million loss, respectively, which was included on the line item “Change in value of the NEC TOKIN option” in the Condensed Consolidated Statement of Operations. The option has been valued using option pricing methods in a Monte Carlo simulation and is impacted by changes in time to maturity, discount rates, interest rates, foreign exchange rates, and NEC TOKIN's projected performance, etc. The line item “Other non-current obligations” on the Condensed Consolidated Balance Sheets includes $24.1 million and $20.6 million as of December 31, 2016 and March 31, 2016 , respectively, related to the respective fair value of the Put Option. KEC’s total investment in NEC TOKIN on February 1, 2013, the closing date of the acquisition, was $54.5 million which includes $50.0 million cash consideration plus approximately $4.5 million in transaction expenses (fees for legal, accounting, due diligence, investment banking and various other services necessary to complete the transactions). The Company has made an allocation of the aggregate purchase price, which was based upon estimates that the Company believes are reasonable. Summarized financial information for NEC TOKIN follows (amounts in thousands): December 31, March 31, Current assets $ 248,128 $ 240,427 Non-current assets 230,232 260,614 Current liabilities 160,648 179,360 Non-current liabilities 322,768 335,500 Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Sales $ 127,845 $ 111,594 $ 374,944 $ 343,686 Gross profit 28,886 24,610 82,487 74,333 Net income (loss) (1) 1,082 (17,867 ) 5,444 (10,606 ) (1) The significant changes between the periods were due to the additional accrual of anti-trust litigation loss recorded during the quarter ended December 31, 2015; see discussion below. A reconciliation between NEC TOKIN’s net income (loss) and KEC’s equity investment income (loss) follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 NEC TOKIN net income (loss) $ 1,082 $ (17,867 ) $ 5,444 $ (10,606 ) KEC’s economic interest % 34 % 34 % 34 % 34 % Equity income (loss) from NEC TOKIN before adjustments 368 (6,075 ) 1,851 (3,606 ) Adjustments: Amortization and depreciation (562 ) (494 ) (1,686 ) (1,118 ) Inventory profit elimination 61 64 106 (34 ) Equity income (loss) from NEC TOKIN $ (133 ) $ (6,505 ) $ 271 $ (4,758 ) A reconciliation between NEC TOKIN’s net assets and KEC’s investment in NEC TOKIN follows (amounts in thousands): December 31, March 31, Investment in NEC TOKIN $ 21,202 $ 20,334 Purchase price accounting basis adjustments: Property, plant and equipment (1) 3,014 3,365 Technology (1) (8,657 ) (10,134 ) Long-term debt (1) (1,238 ) (1,975 ) Goodwill (7,250 ) (7,555 ) Indemnity asset for legal investigation (8,500 ) (8,500 ) Inventory profit elimination (2) 265 371 Other (553 ) (604 ) KEC’s 34% economic interest in NEC TOKIN’s net assets $ (1,717 ) $ (4,698 ) (1) Amortized over the estimated lives. (2) Adjusted each period for any activity. As of December 31, 2016 , KEC’s maximum loss exposure as a result of its investments in NEC TOKIN is limited to the aggregate of the carrying value of the investment, any accounts receivable balance due from NEC TOKIN and obligations in the Put Option. Summarized transactions between KEC and NEC TOKIN are as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 KEC’s sales to NEC TOKIN $ 4,814 $ 5,020 $ 13,096 $ 14,350 NEC TOKIN’s sales to KEMET 2,350 1,157 6,112 4,747 December 31, March 31, Accounts receivable $ 2,989 $ 5,220 Accounts payable 907 1,019 Management service agreement receivable (1) 638 748 (1) In accordance with the Stockholders’ Agreement, KEC entered into a management services agreement with NEC TOKIN to provide services for which KEC is being reimbursed. Beginning in March 2014, NEC TOKIN and certain of its subsidiaries received inquiries, requests for information and other communications from government authorities in China, the United States, the European Commission, Japan, South Korea, Taiwan, Singapore and Brazil concerning alleged anti-competitive activities within the capacitor industry. On September 2, 2015, the United States Department of Justice announced a plea agreement with NEC TOKIN in which NEC TOKIN agreed to plead guilty to a one-count felony charge of unreasonable restraint of interstate and foreign trade and commerce in violation of Section 1 of the Sherman Act, and to pay a criminal fine of $13.8 million . The plea agreement was approved by the United States District Court, Northern District of California, on January 21, 2016. The fine is payable over five years in six installments of $2.3 million each, plus accrued interest. The first and second payments were made in February 2016 and January 2017, respectively, while the next payment is due in January 2018. On December 9, 2015, the Taiwan Fair Trade Commission (“TFTC”) publicly announced that NEC TOKIN would be fined 1,218.2 million New Taiwan dollars (“NTD”) (approximately U.S. $37.7 million ) for violations of the Taiwan Fair Trade Act. Subsequently, the TFTC has reduced the fine to NTD609.1 million (approximately U.S. $18.9 million ). In February 2016, NEC TOKIN commenced an administrative suit in Taiwan, challenging the validity of the amount of the fine, however, the likelihood of success cannot yet be determined. On March 29, 2016, the Japan Fair Trade Commission published an order by which NEC TOKIN was fined ¥ 127.2 million (approximately U.S. $1.1 million ) for violation of the Japanese Antimonopoly Act. Payment of the fine was made on October 31, 2016. On July 26, 2016, Brazil’s Administrative Council for Economic Defense approved a cease and desist agreement with NEC TOKIN in which NEC TOKIN made a financial contribution of Brazilian real 601 thousand (approximately U.S. $0.2 million ) to Brazil’s Fund for Defense of Diffuse Rights. On May 2, 2016, NEC TOKIN reached a preliminary settlement, followed by definitive settlement agreements on July 15, 2016 which are subject to court approval, in two antitrust suits filed with the United States District Court, Northern District of California as In re: Capacitors Antitrust Litigation, No. 3:14-cv-03264-JD (the “Class Action Suits”). Pursuant to the terms of the settlement agreements, in consideration of the release of NEC TOKIN and its subsidiaries (including NEC TOKIN America, Inc.) from claims asserted in the Class Action Suits, NEC TOKIN will pay an aggregate $37.3 million to a settlement class of direct purchasers of capacitors and a settlement class of indirect purchasers of capacitors. Each of the respective class payments is payable in five installments, the first of which became due on July 29, 2016, the next three of which are due each year thereafter on the anniversary of the initial payment, and the final payment is due by December 31, 2019. NEC TOKIN has paid the initial installment payments into the two plaintiff classes’ respective escrow accounts. The remaining governmental investigations are continuing at various stages. As of December 31, 2016 , NEC TOKIN’s accrual for antitrust and civil litigation claims totaled $72.5 million . This amount includes the best estimate of losses which may result from the ongoing antitrust investigations, civil litigation and claims. However, the actual outcomes could differ from what has been accrued. Pursuant to the Stock Purchase Agreement, NEC is required to indemnify NEC TOKIN and/or KEC for any breaches by NEC TOKIN or NEC of certain representations, warranties and covenants in the Stock Purchase Agreement. NEC’s aggregate liability for indemnification claims is limited to $25.0 million . Accordingly, KEMET, under equity method accounting, has established an indemnity asset in the amount of $8.5 million (based upon our 34% economic interest in NEC TOKIN). However, pursuant to the Stock Purchase Agreement, claims arising out of fraud or criminal conduct are not limited by the $25.0 million indemnification cap, and for such claims the claimant retains all remedies available in equity or at law.

Segment and Geographic Informat

Segment and Geographic Information	9 Months Ended
	Dec. 31, 2016
Segment Reporting [Abstract]
Segment and Geographic Information	Segment and Geographic Information The Company is organized into two business groups: Solid Capacitors and Film and Electrolytic. The business groups are responsible for their respective manufacturing sites as well as their respective research and development efforts. The Company does not allocate indirect Selling, general and administrative (“SG&A”) or shared Research and development (“R&D”) expenses to the business groups. Solid Capacitors Operating in nine manufacturing sites in the United States, Mexico and China, Solid Capacitors primarily produces tantalum, aluminum polymer, and ceramic capacitors which are sold globally. Solid Capacitors also produces tantalum powder used in the production of tantalum capacitors and has a product innovation center in the United States. Film and Electrolytic Operating in nine manufacturing sites throughout Europe and Asia, Film and Electrolytic primarily produces film, paper, and electrolytic capacitors which are sold globally. In addition, this business group has product innovation centers in Portugal, Italy, Germany and Sweden. The following table reflects each business group’s net sales, operating income (loss), depreciation and amortization expenses and sales by region for the quarters and nine-month periods ended December 31, 2016 and 2015 (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Net sales: Solid Capacitors $ 141,555 $ 135,300 $ 426,140 $ 416,261 Film and Electrolytic 46,474 41,884 134,132 134,636 $ 188,029 $ 177,184 $ 560,272 $ 550,897 Operating income (loss) (1) (2): Solid Capacitors $ 37,264 $ 31,359 $ 107,753 $ 95,371 Film and Electrolytic 2,332 (1,770 ) (6,231 ) 1,159 Corporate (25,746 ) (21,096 ) (75,724 ) (72,807 ) $ 13,850 $ 8,493 $ 25,798 $ 23,723 Depreciation and amortization expense: Solid Capacitors $ 5,078 $ 5,293 $ 15,643 $ 16,227 Film and Electrolytic 2,560 3,031 8,111 8,901 Corporate 1,457 1,350 4,217 3,728 $ 9,095 $ 9,674 $ 27,971 $ 28,856 __________________ (1) Restructuring charges included in Operating income (loss) are as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Restructuring charges: Solid Capacitors $ (128 ) $ 754 $ 566 $ 1,556 Film and Electrolytic (243 ) 987 3,421 1,524 Corporate 2 (27 ) 330 481 $ (369 ) $ 1,714 $ 4,317 $ 3,561 (2) Write down of long-lived assets included in Operating income (loss) are as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Write down of Long-lived Assets Solid Capacitors $ — $ — $ 2,076 $ — Film and Electrolytic — — 4,117 — $ — $ — $ 6,193 $ — ___________________ Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Sales by region: North and South America (“Americas”) $ 54,976 $ 56,411 $ 166,858 $ 170,525 Europe, Middle East, Africa (“EMEA”) 55,765 52,453 176,298 173,468 Asia and Pacific Rim (“APAC”) 77,288 68,320 217,116 206,904 $ 188,029 $ 177,184 $ 560,272 $ 550,897

Defined Benefit Pension and Oth

Defined Benefit Pension and Other Postretirement Benefit Plans	9 Months Ended
	Dec. 31, 2016
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	Defined Benefit Pension and Other Postretirement Benefit Plans The Company sponsors six defined benefit pension plans in Europe, one plan in Singapore and two plans in Mexico. In addition, the Company sponsors a post-retirement plan in the United States. Costs recognized for benefit plans are recorded using estimated amounts which may change as actual costs for the fiscal year are determined. The components of net periodic benefit (income) costs relating to the Company’s pension and other postretirement benefit plans are as follows for the quarters ended December 31, 2016 and 2015 (amounts in thousands): Pension Post-retirement Benefit Plan Quarters Ended December 31, Quarters Ended December 31, 2016 2015 2016 2015 Net service cost $ 347 $ 404 $ — $ — Interest cost 358 338 1 3 Expected return on net assets (94 ) (105 ) — — Amortization: Actuarial (gain) loss 115 197 (71 ) (64 ) Prior service cost 21 15 — — Total net periodic benefit (income) costs $ 747 $ 849 $ (70 ) $ (61 ) The components of net periodic benefit (income) costs relating to the Company’s pension and other postretirement benefit plans are as follows for the nine-month periods ended December 31, 2016 and 2015 (amounts in thousands): Pension Post-retirement Benefit Plan Nine-Month Periods Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Net service cost $ 1,040 $ 1,514 $ — $ — Interest cost 1,076 1,013 9 14 Expected return on net assets (283 ) (315 ) — — Amortization: Actuarial (gain) loss 345 591 (155 ) (143 ) Prior service cost 64 44 — — Total net periodic benefit (income) costs $ 2,242 $ 2,847 $ (146 ) $ (129 ) In fiscal year 2017 , the Company expects to contribute up to $1.7 million to the pension plans, $0.8 million of which has been contributed as of December 31, 2016 . For the postretirement benefit plan, the Company’s policy is to pay benefits as costs are incurred.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-based Compensation	Stock-based Compensation As of December 31, 2016 , the 2014 Amendment and Restatement of the KEMET Corporation 2011 Omnibus Equity Incentive Plan (the “2011 Incentive Plan”), approved by the Company’s stockholders in 2014, is the only plan the Company has to issue equity based awards to executives and key employees. Upon adoption of the 2011 Incentive Plan, no further awards were permitted to be granted under the Company’s prior plans, including the 1992 Key Employee Stock Option Plan, the 1995 Executive Stock Option Plan, and the 2004 Long-Term Equity Incentive Plan (collectively, the “Prior Plans”). The 2011 Incentive Plan authorized the grant of up to 7.4 million shares of the Company’s Common Stock, comprised of 6.6 million shares under the 2011 Incentive Plan and 0.8 million shares remaining from the Prior Plans and authorizes the Company to provide equity-based compensation in the form of: • stock options, including incentive stock options, entitling the optionee to favorable tax treatment under Section 422 of the Code; • stock appreciation rights; • restricted stock and restricted stock units (“RSUs”); • other share-based awards; and, • performance awards. Except as described below, options, restricted stock and RSUs issued under these plans vest within two to three years and expire ten years from the grant date. RSUs issued under these plans vest over three to four years, except for RSUs granted to members of the Board of Directors, which vest within one year, and performance-based RSUs, which vest over a one -year period following achievement of two-year performance targets. The Company grants RSUs to members of the Board of Directors, the Chief Executive Officer and key management. Once vested and settled, RSUs are converted into restricted stock. For members of the Board of Directors and senior personnel, such restricted stock cannot be sold until 90 days after termination of service with the Company, or until the individual achieves the targeted ownership under the Company’s stock ownership guidelines, and only to the extent that such ownership level exceeds the target. Compensation expense is recognized over the respective vesting periods. Historically, the Board of Directors of the Company has approved annual Long Term Incentive Plans (“LTIP”) which cover two year periods and are primarily based upon the achievement of an Adjusted EBITDA range for the two-year period. At the time of the award, the individual plans entitle the participants to receive cash or RSUs, or a combination of both as determined by the Company’s Board of Directors. The 2013/2014 LTIP, 2014/2015 LTIP, 2015/2016 LTIP, 2016/2017 LTIP, and 2017/2018 LTIP also awarded RSUs which vest over the course of three years from the anniversary of the establishment of the plan and are not subject to a performance metric. The Company assesses the likelihood of meeting the Adjusted EBITDA financial metric on a quarterly basis and adjusts compensation expense to match expectations. Any related liability is reflected in the line item “Accrued expenses” on the Condensed Consolidated Balance Sheets and any restricted stock unit commitment is reflected in the line item “Additional paid-in capital” on the Condensed Consolidated Balance Sheets. On May 18, 2016, the Company granted RSUs under the 2017/2018 LTIP with a grant date fair value of $2.46 that vests as follows (amounts in thousands): Shares May 18, 2017 202 May 18, 2018 202 May 18, 2019 209 Total shares granted 613 The following is the vesting schedule of RSUs under each respective LTIP, which vested during the nine-month period ended December 31, 2016 (shares in thousands): 2016/2017 2015/2016 2014/2015 Time-based award vested 187 111 130 Performance-based award vested — 103 73 Restricted stock activity, excluding the LTIP activity discussed above, for the nine-month period ended December 31, 2016 is as follows (amounts in thousands except fair value): Shares Weighted- Non-vested restricted stock at March 31, 2016 1,430 $ 3.51 Granted 381 4.82 Vested (328 ) 3.06 Forfeited (20 ) 3.19 Non-vested restricted stock at December 31, 2016 1,463 $ 5.21 The compensation expense associated with stock-based compensation for the quarters ended December 31, 2016 and 2015 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands): Quarter Ended December 31, 2016 Quarter Ended December 31, 2015 Stock Options Restricted Stock LTIPs Stock Options Restricted Stock LTIPs Cost of sales $ 3 $ 127 $ 178 $ 11 $ 130 $ 127 Selling, general and administrative expenses 4 379 402 11 340 474 Research and development — 5 41 1 6 54 Total $ 7 $ 511 $ 621 $ 23 $ 476 $ 655 The compensation expense associated with stock-based compensation for the nine-month periods ended December 31, 2016 and 2015 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands): Nine-Month Period Ended December 31, 2016 Nine-Month Period Ended December 31, 2015 Stock Options Restricted Stock LTIPs Stock Options Restricted Stock LTIPs Cost of sales $ 21 $ 415 $ 557 $ 72 $ 444 $ 624 Selling, general and administrative expenses 20 1,072 1,232 79 1,033 1,365 Research and development 1 15 138 4 17 123 Total $ 42 $ 1,502 $ 1,927 $ 155 $ 1,494 $ 2,112 In the “Operating activities” section of the Condensed Consolidated Statements of Cash Flows, stock-based compensation expense was treated as an adjustment to Net income (loss) for the quarters and nine-month periods ended December 31, 2016 , and 2015 . Sixteen thousand stock options were exercised in the nine-month periods ended December 31, 2016 and no stock options were exercised in the nine-month periods ended December 31, 2015 .

Income Taxes

Income Taxes	9 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes During the quarter ended December 31, 2016 , the Company recognized $1.8 million of income tax expense, comprised of $1.7 million of income tax expense related to foreign operations and $0.1 million of state income tax expense. During the nine-month period ended December 31, 2016 , the Company recognized $4.4 million of income tax expense, comprised of $4.3 million of income tax expense related to foreign operations and $0.1 million of state income tax expense. During the quarter ended December 31, 2015 , the Company recognized $2.8 million of income tax expense from foreign operations. During the nine-month period ended December 31, 2015 , the Company recognized $4.0 million of income tax expense, comprised of $4.4 million from foreign operations, $0.6 million of income tax benefit due to the reduction in the U.S. valuation allowance associated with the acquisition of IntelliData, Inc., and $0.2 million of state income tax expense. There was no U.S. federal income tax benefit from net operating losses for the quarter and nine-month periods ended December 31, 2016 and 2015 due to a valuation allowance recorded on deferred tax assets.

Basic and Diluted Net Income (L

Basic and Diluted Net Income (Loss) Per Common Share	9 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Basic and Diluted Net Income (Loss) Per Common Share	Basic and Diluted Net Income (Loss) Per Common Share The following table presents basic earnings per share (“EPS”) and diluted EPS (amounts in thousands, except per share data): Quarters Ended December 31, Nine-Month Periods Ended 2016 2015 2016 2015 Numerator: Net income (loss) $ 12,278 $ (8,600 ) $ (4,925 ) $ (38,456 ) Denominator: Weighted-average shares outstanding: Basic 46,606 46,081 46,469 45,953 Assumed conversion of employee stock grants 2,122 — — — Assumed conversion of warrants 6,568 — — — Diluted 55,296 46,081 46,469 45,953 Net income (loss) per basic share $ 0.26 $ (0.19 ) $ (0.11 ) $ (0.84 ) Net income (loss) per diluted share $ 0.22 $ (0.19 ) $ (0.11 ) $ (0.84 ) Common stock equivalents that could potentially dilute net income (loss) per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been anti-dilutive, are as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Assumed conversion of employee stock grants 800 3,257 2,760 3,247 Assumed conversion of warrants — 5,168 5,913 5,261

Derivatives

Derivatives	9 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives In fiscal year 2015, the Company began using certain derivative instruments (i.e., foreign exchange contracts) to reduce exposure to the volatility of foreign currencies impacting revenues and the costs of its products. Certain operating expenses at the Company’s Mexican facilities are paid in Mexican pesos. In order to hedge a portion of these forecasted cash flows, the Company purchases foreign exchange contracts, with terms generally less than twelve months, to buy Mexican pesos for periods and amounts consistent with underlying cash flow exposures. These contracts are designated as cash flow hedges at inception and monitored for effectiveness on a routine basis. There were $47.5 million in peso contracts (notional value) outstanding at December 31, 2016 . The Company formally documents all relationships between hedging instruments and hedged items, as well as risk management objectives and strategies for undertaking various hedge transactions. The Company records and presents the fair values of all of its derivative assets and liabilities in the Consolidated Balance Sheets on a net basis, since they are subject to master netting agreements. As of December 31, 2016 , no netting took place, as all contracts were in the liability position. The balance sheet classifications and fair value of derivative instruments as of December 31, 2016 are as follows (amounts in thousands): Fair Value of Derivative Instruments (1) Accrued expenses $ 3,240 ______________________________________________________________________________ (1) Fair Value measured using Level 2 inputs by adjusting the market spot rate by forward points, based on the date of the contract. The spot rates and forward points used are based on an average rate from an actively traded market. The impact on the Consolidated Statement of Operations for the quarter and nine-month period ended December 31, 2016 are as follows (amounts in thousands): Impact of Foreign Exchange Contracts on Condensed Consolidated Statement of Operations Statement Caption Quarter Ended December 31, 2016 Nine-Month Period Ended December 31, 2016 Net Sales $ — $ — Operating costs and expenses: Cost of sales (980 ) (3,873 ) Total operating costs and expenses (980 ) (3,873 ) Operating income (loss) $ (980 ) $ (3,873 ) Unrealized gains and losses associated with the change in value of these financial instruments are recorded in AOCI. Changes in the derivatives’ fair values are deferred and recorded as a component of AOCI until the underlying transaction is settled and recorded to the income statement. When the hedged item affects income, gains or losses are reclassified from AOCI to the Consolidated Statement of Operations as Cost of sales for foreign exchange contracts to purchase such foreign currency. Any ineffectiveness, if material, in the Company’s hedging relationships is recognized immediately as a loss, within the same income statement accounts as described above; to date, there has been no ineffectiveness. Changes in derivative balances impact the line items “Prepaid and other assets” and “Accrued expenses” on the Consolidated Balance Sheets and Statements of Cash Flows.

Concentrations of Risks

Concentrations of Risks	9 Months Ended
	Dec. 31, 2016
Risks and Uncertainties [Abstract]
Concentrations of Risks	Concentrations of Risks The Company sells to customers globally and, as the Company generally does not require collateral from its customers, on a monthly basis the Company evaluates customer account balances in order to assess the Company’s financial risks of collection. One customer, TTI, Inc., an electronics distributor, accounted for over 10% of the Company’s net sales in the quarters and nine-month periods ended December 31, 2016 and 2015 . There were no accounts receivable balances from any customer exceeding 10% of gross accounts receivable as of December 31, 2016 and March 31, 2016 . Electronics distributors are an important distribution channel in the electronics industry and accounted for 46% and 41% of the Company’s net sales in the nine-month periods ended December 31, 2016 and 2015 , respectively. As a result of the Company’s concentration of sales to electronics distributors, the Company may experience fluctuations in the Company’s operating results as electronics distributors experience fluctuations in end-market demand and/or adjust their inventory stocking levels.

Condensed Consolidating Financi

Condensed Consolidating Financial Statements	9 Months Ended
	Dec. 31, 2016
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Condensed Consolidating Financial Statements	Condensed Consolidating Financial Statements The 10.5% Senior Notes are fully and unconditionally guaranteed, jointly and severally, on a senior basis by certain of the Company’s 100% owned domestic subsidiaries (“Guarantor Subsidiaries”) and secured by a first priority lien on 51% of the capital stock of certain of our foreign restricted subsidiaries (“Non-Guarantor Subsidiaries”). The Company’s Guarantor Subsidiaries and Non-Guarantor Subsidiaries are not consistent with the Company’s business groups or geographic operations; accordingly, this basis of presentation is not intended to present the Company’s financial condition, results of operations or cash flows for any purpose other than to comply with the specific requirements for subsidiary guarantor reporting. The Company is required to present condensed consolidating financial information in order for the subsidiary guarantors of the Company’s public debt to be exempt from reporting under the Securities Exchange Act of 1934, as amended. The following subsidiaries comprise the Guarantor Subsidiaries: KEMET Electronics Corporation, KEMET Blue Powder Corporation, KEMET Foil Manufacturing, LLC, KEMET Services Corporation, The Forest Electric Company and IntelliData Inc. The following subsidiaries comprise the Non-Guarantor Subsidiaries group: KEMET Electronics Bulgaria EAD, KEMET Electronics Services EOOD, KEMET Electronics Oy, KEMET Electronics SAS, KEMET Electronics GmbH, KEMET Electronics Asia Limited, KEMET Electronics Greater China Limited, P.T. KEMET Electronics Indonesia, KEMET Electronics Italia S.r.l., KEMET Electronics S.p.A., KEMET Electronics Japan Co., Ltd., KEMET Electronics Macedonia DOOEL Skopje, KEMET Electronics (Malaysia) Sdn. Bhd., KEMET de Mexico, S.A. de C.V., KEMET Electronics (Suzhou) Co., Ltd., Shanghai Arcotronics Components & Machineries Co., Ltd., KEMET Electronics Portugal, S.A., Evox Rifa Pte Ltd., KEMET Electronics Marketing (S) Pte Ltd., Seoryong Singapore Pte. Ltd., KEMET Electronics AB, KEMET Electronics, S.A. and KEMET Electronics Limited. Condensed consolidating financial statements for the Company’s Guarantor Subsidiaries and Non-Guarantor Subsidiaries are presented in the following tables (amounts in thousands): Condensed Consolidating Balance Sheet December 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated ASSETS Current assets: Cash and cash equivalents $ 729 $ 46,038 $ 40,589 $ — $ 87,356 Accounts receivable, net — 26,500 56,019 — 82,519 Intercompany receivable 32,874 195,280 149,763 (377,917 ) — Inventories, net — 102,559 51,960 — 154,519 Prepaid expenses and other 3,325 11,976 11,698 (2,964 ) 24,035 Total current assets 36,928 382,353 310,029 (380,881 ) 348,429 Property and equipment, net 498 81,692 129,737 — 211,927 Goodwill — 40,294 — — 40,294 Intangible assets, net — 25,020 5,184 — 30,204 Investment in NEC TOKIN — 21,202 — — 21,202 Investments in subsidiaries 394,561 427,702 93,359 (915,622 ) — Deferred income taxes — 1,045 6,723 — 7,768 Other assets 27 1,779 906 — 2,712 Long-term intercompany receivable 62,496 38,356 1,089 (101,941 ) — Total assets $ 494,510 $ 1,019,443 $ 547,027 $ (1,398,444 ) $ 662,536 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable 40 30,601 31,706 — 62,347 Intercompany payable 42,935 270,738 64,244 (377,917 ) — Accrued expenses 8,743 19,334 18,341 — 46,418 Income taxes payable — 3,007 1,025 (2,964 ) 1,068 Total current liabilities 51,718 323,680 115,316 (380,881 ) 109,833 Long-term debt, less current portion 352,345 19,881 14,000 — 386,226 Other non-current obligations — 27,399 45,305 — 72,704 Deferred income taxes — 2,556 770 — 3,326 Long-term intercompany payable — 62,496 39,445 (101,941 ) — Stockholders’ equity 90,447 583,431 332,191 (915,622 ) 90,447 Total liabilities and stockholders’ equity $ 494,510 $ 1,019,443 $ 547,027 $ (1,398,444 ) $ 662,536 Condensed Consolidating Balance Sheet March 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated ASSETS Current assets: Cash and cash equivalents $ 640 $ 36,209 $ 28,155 $ — $ 65,004 Accounts receivable, net — 41,025 52,143 — 93,168 Intercompany receivable 30,210 132,523 170,224 (332,957 ) — Inventories, net — 113,289 55,590 — 168,879 Prepaid expenses and other 3,325 12,161 12,974 (2,964 ) 25,496 Total current assets 34,175 335,207 319,086 (335,921 ) 352,547 Property and equipment, net 255 93,936 147,648 — 241,839 Goodwill — 40,294 — — 40,294 Intangible assets, net — 27,252 6,049 — 33,301 Investment in NEC TOKIN — 20,334 — — 20,334 Investments in subsidiaries 382,108 429,723 93,359 (905,190 ) — Deferred income taxes — 800 7,597 — 8,397 Other assets — 2,452 616 — 3,068 Long-term intercompany receivable 67,500 41,428 1,088 (110,016 ) — Total assets $ 484,038 $ 991,426 $ 575,443 $ (1,351,127 ) $ 699,780 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 2,000 $ — $ — $ — $ 2,000 Accounts payable 20 34,618 36,343 — 70,981 Intercompany payable 280 275,498 57,179 (332,957 ) — Accrued expenses 17,305 11,807 21,208 — 50,320 Income taxes payable — 2,983 434 (2,964 ) 453 Total current liabilities 19,605 324,906 115,164 (335,921 ) 123,754 Long-term debt, less current portion 351,952 19,881 14,000 — 385,833 Other non-current obligations — 25,797 49,095 — 74,892 Deferred income taxes — 2,242 578 — 2,820 Long-term intercompany payable — 67,500 42,516 (110,016 ) — Stockholders’ equity 112,481 551,100 354,090 (905,190 ) 112,481 Total liabilities and stockholders’ equity $ 484,038 $ 991,426 $ 575,443 $ (1,351,127 ) $ 699,780 Condensed Consolidating Statement of Operations For the Quarter Ended December 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Net sales $ — $ 211,214 $ 179,921 $ (203,106 ) $ 188,029 Operating costs and expenses: Cost of sales 257 163,260 166,866 (189,691 ) 140,692 Selling, general and administrative expenses 11,695 16,590 11,795 (13,415 ) 26,665 Research and development 72 4,708 2,279 — 7,059 Restructuring charges — (466 ) 97 — (369 ) Write down of long-lived assets — (1,608 ) 1,608 — — Net (gain) loss on sales and disposals of assets (7 ) 109 30 — 132 Total operating costs and expenses 12,017 182,593 182,675 (203,106 ) 174,179 Operating income (loss) (12,017 ) 28,621 (2,754 ) — 13,850 Non-operating (income) expense: Interest income — — (5 ) — (5 ) Interest expense 9,395 383 140 — 9,918 Change in value of NEC TOKIN option — (6,900 ) — — (6,900 ) Other (income) expense, net (10,479 ) 11,671 (4,576 ) — (3,384 ) Equity in earnings of subsidiaries (23,211 ) — — 23,211 — Income (loss) before income taxes and equity income (loss) from NEC TOKIN 12,278 23,467 1,687 (23,211 ) 14,221 Income tax expense (benefit) — 37 1,773 — 1,810 Income (loss) before equity income (loss) from NEC TOKIN 12,278 23,430 (86 ) (23,211 ) 12,411 Equity income (loss) from NEC TOKIN — (133 ) — — (133 ) Net income (loss) $ 12,278 $ 23,297 $ (86 ) $ (23,211 ) $ 12,278 Condensed Consolidating Statements of Comprehensive Income (Loss) Quarter Ended December 31, 2016 (Unaudited) Comprehensive income (loss) $ 8,602 $ 29,828 $ (8,438 ) $ (23,211 ) $ 6,781 Condensed Consolidating Statement of Operations For the Quarter Ended December 31, 2015 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Net sales $ — $ 211,268 $ 170,531 $ (204,615 ) $ 177,184 Operating costs and expenses: Cost of sales 232 173,368 156,669 (191,833 ) 138,436 Selling, general and administrative expenses 8,306 16,207 10,547 (12,782 ) 22,278 Research and development 79 4,232 1,823 — 6,134 Restructuring charges — 726 988 — 1,714 Net (gain) loss on sales and disposals of assets — (348 ) 477 — 129 Total operating costs and expenses 8,617 194,185 170,504 (204,615 ) 168,691 Operating income (loss) (8,617 ) 17,083 27 — 8,493 Non-operating (income) expense: Interest income — — (4 ) — (4 ) Interest expense 9,461 267 124 — 9,852 Change in value of NEC TOKIN option — (700 ) — — (700 ) Other (income) expense, net (7,931 ) 7,997 (1,386 ) — (1,320 ) Equity in earnings of subsidiaries (1,547 ) — — 1,547 — Income (loss) before income taxes and equity income (loss) from NEC TOKIN (8,600 ) 9,519 1,293 (1,547 ) 665 Income tax expense (benefit) — 44 2,716 — 2,760 Income (loss) before equity income (loss) from NEC TOKIN (8,600 ) 9,475 (1,423 ) (1,547 ) (2,095 ) Equity income (loss) from NEC TOKIN — (6,505 ) — — (6,505 ) Net income (loss) $ (8,600 ) $ 2,970 $ (1,423 ) $ (1,547 ) $ (8,600 ) Condensed Consolidating Statements of Comprehensive Income (Loss) For the Quarter Ended December 31, 2015 (Unaudited) Comprehensive income (loss) $ (10,474 ) $ 4,604 $ 517 $ (1,547 ) $ (6,900 ) Condensed Consolidating Statement of Operation For the Nine-Month Period Ended December 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Net sales $ — $ 642,253 $ 519,814 $ (601,795 ) $ 560,272 Operating costs and expenses: Cost of sales 1,023 499,922 485,391 (562,337 ) 423,999 Selling, general and administrative expenses 31,471 52,796 33,743 (39,459 ) 78,551 Research and development 228 13,581 7,298 — 21,107 Restructuring charges — 3,125 1,192 — 4,317 Write down of long-lived assets — 4,585 1,608 — 6,193 Net (gain) loss on sales and disposals of assets (292 ) 1,132 (533 ) — 307 Total operating costs and expenses 32,430 575,141 528,699 (601,796 ) 534,474 Operating income (loss) (32,430 ) 67,112 (8,885 ) 1 25,798 Non-operating (income) expense: Interest income — 3 (17 ) — (14 ) Interest expense 28,214 1,161 376 — 29,751 Change in value of NEC TOKIN option — 3,500 — — 3,500 Other (income) expense, net (28,672 ) 29,556 (7,567 ) — (6,683 ) Equity in earnings of subsidiaries (27,047 ) — — 27,047 — Income (loss) before income taxes and equity income (loss) from NEC TOKIN (4,925 ) 32,892 (1,677 ) (27,046 ) (756 ) Income tax expense (benefit) — 94 4,346 — 4,440 Income (loss) before equity income (loss) from NEC TOKIN (4,925 ) 32,798 (6,023 ) (27,046 ) (5,196 ) Equity income (loss) from NEC TOKIN — 271 — — 271 Net income (loss) $ (4,925 ) $ 33,069 $ (6,023 ) $ (27,046 ) $ (4,925 ) Condensed Consolidating Statements of Comprehensive Income (Loss) For the Nine-Month Period Ended December 31, 2016 (Unaudited) Comprehensive income (loss) $ (9,929 ) $ 32,331 $ (19,880 ) $ (27,046 ) $ (24,524 ) Condensed Consolidating Statement of Operations For the Nine-Month Period Ended December 31, 2015 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Net sales $ — $ 655,808 $ 527,604 $ (632,515 ) $ 550,897 Operating costs and expenses: Cost of sales 931 528,352 490,621 (590,274 ) 429,630 Selling, general and administrative expenses 27,028 56,197 34,672 (42,241 ) 75,656 Research and development 26 12,834 5,700 — 18,560 Restructuring charges — 2,182 1,379 — 3,561 Net (gain) loss on sales and disposals of assets (7 ) (1,101 ) 875 — (233 ) Total operating costs and expenses 27,978 598,464 533,247 (632,515 ) 527,174 Operating income (loss) (27,978 ) 57,344 (5,643 ) — 23,723 Non-operating (income) expense: Interest income — — (10 ) — (10 ) Interest expense 28,395 865 416 — 29,676 Change in value of NEC TOKIN option — 26,300 — — 26,300 Other (income) expense, net (25,484 ) 25,065 (2,076 ) — (2,495 ) Equity in earnings of subsidiaries 7,567 — — (7,567 ) — Income (loss) before income taxes and equity income (loss) from NEC TOKIN (38,456 ) 5,114 (3,973 ) 7,567 (29,748 ) Income tax expense (benefit) — (320 ) 4,270 — 3,950 Income (loss) before equity income (loss) from NEC TOKIN (38,456 ) 5,434 (8,243 ) 7,567 (33,698 ) Equity income (loss) from NEC TOKIN — (4,758 ) — — (4,758 ) Net income (loss) $ (38,456 ) $ 676 $ (8,243 ) $ 7,567 $ (38,456 ) Condensed Consolidating Statements of Comprehensive Income (Loss) For the Nine-Month Period Ended December 31, 2015 (Unaudited) Comprehensive income (loss) $ (37,698 ) $ (7,109 ) $ (6,107 ) $ 7,567 $ (43,347 ) Condensed Consolidating Statement of Cash Flows For the Nine-Month Period Ended December 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Sources (uses) of cash and cash equivalents Net cash provided by (used in) operating activities $ 2,942 $ 14,962 $ 24,240 $ — $ 42,144 Investing activities: Capital expenditures — (5,133 ) (9,878 ) — (15,011 ) Net cash used in investing activities — (5,133 ) (9,878 ) — (15,011 ) Financing activities: Payments of long-term obligations (1,870 ) — (558 ) — (2,428 ) Proceeds from exercise of stock options 69 — — — 69 Purchase of treasury stock (1,052 ) — — — (1,052 ) Net cash provided by (used in) financing activities (2,853 ) — (558 ) — (3,411 ) Net increase (decrease) in cash and cash equivalents 89 9,829 13,804 — 23,722 Effect of foreign currency fluctuations on cash — — (1,370 ) — (1,370 ) Cash and cash equivalents at beginning of fiscal period 640 36,209 28,155 — 65,004 Cash and cash equivalents at end of fiscal period $ 729 $ 46,038 $ 40,589 $ — $ 87,356 Condensed Consolidating Statements of Cash Flows For the Nine-Month Period Ended December 31, 2015 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Sources (uses) of cash and cash equivalents Net cash provided by (used in) operating activities $ 691 $ (8,085 ) $ 6,837 $ — $ (557 ) Investing activities: Capital expenditures — (6,221 ) (7,899 ) — (14,120 ) Proceeds from sale of assets — 247 651 — 898 Acquisitions, net of cash received — (2,892 ) — — (2,892 ) Net cash used in investing activities — (8,866 ) (7,248 ) — (16,114 ) Financing activities: Proceeds from revolving line of credit — 8,000 2,000 — 10,000 Payments of revolving line of credit — (5,500 ) — — (5,500 ) Payments of long-term obligations — — (481 ) — (481 ) Purchase of treasury stock (691 ) — — — (691 ) Net cash provided by (used in) financing activities (691 ) 2,500 1,519 — 3,328 Net increase (decrease) in cash and cash equivalents — (14,451 ) 1,108 — (13,343 ) Effect of foreign currency fluctuations on cash — — 139 — 139 Cash and cash equivalents at beginning of fiscal period 640 33,094 22,628 — 56,362 Cash and cash equivalents at end of fiscal period $ 640 $ 18,643 $ 23,875 $ — $ 43,158

Basis of Financial Statement 21

Basis of Financial Statement Presentation (Policies)	9 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Use of Estimates and Assumptions	Use of Estimates and Assumptions The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and judgments based on historical data and other assumptions that management believes are reasonable. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period. The Company’s judgments are based on management’s assessment as to the effect certain estimates, assumptions, or future trends or events may have on the financial condition and results of operations reported in the unaudited condensed consolidated financial statements. It is important that readers of these unaudited financial statements understand that actual results could differ from these estimates, assumptions, and judgments.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements New accounting standards adopted/issued In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-16, Income Taxes - Intra-Entity Transfers of Assets Other Than Inventory. The update requires entities to recognize the income tax consequences of many intercompany asset transfers at the transaction date. The seller and buyer will immediately recognize the current and deferred income tax consequences of an intercompany transfer of an asset other than inventory. The tax consequences were previously deferred. The effective date of this update is for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The update requires modified retrospective transition method which is a cumulative effect adjustment to retained earnings as of the beginning of the first effective reporting period. The Company is currently evaluating the impact of the adoption of this guidance on the Company’s consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The update clarifies how cash receipts and cash payments in certain transactions are presented and classified in the statement of cash flows. The effective date of this update is for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The update requires retrospective application to all periods presented but may be applied prospectively if retrospective application is impracticable. The Company is currently evaluating the impact of the adoption of this guidance on the Company’s consolidated financial statements. In March 2016, the FASB issued ASU No. 2016-09, Compensation-Stock Compensation. This guidance changes several aspects of the accounting for share-based payment award transactions, including: (1) Accounting and Cash Flow Classification for Excess Tax Benefits and Deficiencies, (2) Forfeitures, and (3) Tax Withholding Requirements and Cash Flow Classification. This ASU is effective for fiscal years and interim periods within those years beginning after December 15, 2016. Early application is permitted, and KEMET adopted ASU No. 2016-09 as of April 1, 2016. The Company elected to discontinue estimating forfeitures that are expected to occur and recorded a cumulative effect adjustment to retained earnings of $130,000 as of April 1, 2016. There was no cumulative adjustment related to the excess tax benefits as the Company did not have an additional paid in capital pool of excess tax benefits. The adoption did not have a significant impact on the Company’s consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases. The ASU requires lessees to recognize a right-of-use asset and a lease liability for virtually all of their leases (other than short-term leases). The guidance is to be applied using a modified retrospective approach at the beginning of the earliest comparative period in the financial statements. This ASU is effective for fiscal years and interim periods within those years beginning after December 15, 2018. Early application is permitted. The Company is currently in the process of assessing the impact the adoption of this guidance will have on the Company’s consolidated financial statements. In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory. The ASU requires an entity that uses first-in, first-out or average cost to measure its inventory at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. ASU 2015-11 was effective for interim and annual reporting periods beginning April 1, 2016. The adoption of ASU 2015-11 did not materially impact the Company’s operating results and financial position. In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The ASU specifies that debt issuance costs related to a note shall be reported in the balance sheet as a direct reduction from the face amount of the note. In August 2015, the FASB issued ASU No. 2015-15, Interest - Imputation of Interest (Subtopic 835-30) - Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements, which clarifies the treatment of debt issuance costs associated with line-of-credit arrangements that were not specifically addressed in ASU 2015-03. ASU 2015-15 states that entities may elect to continue to treat debt issuance costs associated with lines of credit as an asset, consistent with current treatment. The Company adopted these ASUs in the first quarter of fiscal year 2017. The ASUs did not impact the Company’s results of operations or liquidity. The balance sheet as of March 31, 2016 has been adjusted to reflect retrospective application of the new accounting guidance as follows (amounts in thousands): As Previously Reported Retrospective Adjustment As Adjusted Other assets $ 5,832 $ (2,764 ) $ 3,068 Total assets 702,544 (2,764 ) 699,780 Long-term debt, less current portion 388,597 (2,764 ) 385,833 Total liabilities and stockholders’ equity 702,544 (2,764 ) 699,780 In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern. The new guidance requires management to assess if there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim period. If conditions or events give rise to substantial doubt, disclosures are required. ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual and interim periods thereafter; early application is permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which supersedes existing accounting standards for revenue recognition and creates a single framework. The new guidance requires either a retrospective or a modified retrospective approach at adoption. Additional updates to Topic 606 issued by the FASB in 2015 and 2016 include the following: • ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which defers the effective date of the new guidance such that the new provisions will now be required for fiscal years, and interim periods within those years, beginning after December 15, 2017 (ASU No. 2015-14 is effective for the Company’s fiscal year that begins on April 1, 2018 and interim periods within that fiscal year). • ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, which clarifies the implementation guidance on principal versus agent considerations (reporting revenue gross versus net). • ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which clarifies the implementation guidance on identifying performance obligations and classifying licensing arrangements. • ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which clarifies the implementation guidance in a number of other areas. • ASU No. 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. The effective date of this guidance is for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted , but not before the Company’s fiscal year that begins on April 1, 2017 (the original effective date of the ASU). The Company plans to adopt the requirements of the new standard in the first quarter of fiscal year 2019. The Company is currently in the process of assessing the impact the adoption of the new revenue standards will have on its consolidated financial statements and related disclosures. There are currently no other accounting standards that have been issued that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption.
Fair Value Measurement	Fair Value Measurement The Company utilizes three levels of inputs to measure the fair value of (a) nonfinancial assets and liabilities that are recognized or disclosed at fair value in the Company’s consolidated financial statements on a recurring basis (at least annually) and (b) all financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The first two inputs are considered observable and the last is considered unobservable. The levels of inputs are as follows: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Inventories	Inventories Inventories are stated at the lower of cost or market.
Warrant	Warrant As of December 31, 2016 and March 31, 2016 , 8.4 million shares were subject to the warrant (which expires June 30, 2019) held by K Equity, LLC.
Revenue Recognition	Revenue Recognition The Company ships products to customers based upon firm orders and revenue is recognized when the sales process is complete. This occurs when products are shipped to the customer in accordance with the terms of an agreement of sale, there is a fixed or determinable selling price, title and risk of loss have been transferred and collectability is reasonably assured. Based on product availability, customer requirements and customer consent, the Company may ship products earlier than the initial planned ship date. Shipping and handling costs are included in cost of sales. A portion of sales is related to products designed to meet customer specific requirements. These products typically have stricter tolerances making them useful to the specific customer requesting the product and to customers with similar or less stringent requirements. The Company recognizes revenue when title to the products transfers to the customer. A portion of sales is made to distributors under agreements allowing certain rights of return and price protection on unsold merchandise held by distributors. The Company’s distributor policy includes inventory price protection and “ship-from-stock and debit” (“SFSD”) programs common in the industry. KEMET’s SFSD program provides authorized distributors with the flexibility to meet marketplace prices by allowing them, upon a pre-approved case-by-case basis, to adjust their purchased inventory cost to correspond with current market demand. Requests for SFSD adjustments are considered on an individual basis, require a pre-approved cost adjustment quote from their local KEMET sales representative and apply only to a specific customer, part, specified special price amount, specified quantity, and are only valid for a specific period of time. To estimate potential SFSD adjustments corresponding with current period sales, KEMET records a sales reserve based on historical SFSD credits, distributor inventory levels, and certain accounting assumptions, all of which are reviewed quarterly. Most of the Company’s distributors have the right to return to KEMET a certain portion of the purchased inventory, which, in general, does not exceed 6% of their purchases from the previous fiscal quarter. KEMET estimates future returns based on historical return patterns and records a corresponding allowance on the Condensed Consolidated Balance Sheets. The Company also offers volume based rebates on a case-by-case basis to certain customers in each of the Company’s sales channels. The establishment of sales allowances is recognized as a component of the line item “Net sales” on the Condensed Consolidated Statements of Operations, while the associated reserves are included in the line item “Accounts receivable, net” on the Condensed Consolidated Balance Sheets. Estimates used in determining sales allowances are subject to various factors. This includes, but is not limited to, changes in economic conditions, pricing changes, product demand, inventory levels in the supply chain, the effects of technological change, and other variables that might result in changes to the Company’s estimates. The Company provides a limited warranty to customers that the Company’s products meet certain specifications. The warranty period is generally limited to one year , and the Company’s liability under the warranty is generally limited to a replacement of the product or refund of the purchase price of the product. Warranty costs as a percentage of net sales were less than 1.0% for the quarters and nine-month periods ended December 31, 2016 and 2015 . The Company recognizes warranty costs when they are both probable and reasonably estimable.

Basis of Financial Statement 22

Basis of Financial Statement Presentation (Tables)	9 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of new accounting pronouncements	The balance sheet as of March 31, 2016 has been adjusted to reflect retrospective application of the new accounting guidance as follows (amounts in thousands): As Previously Reported Retrospective Adjustment As Adjusted Other assets $ 5,832 $ (2,764 ) $ 3,068 Total assets 702,544 (2,764 ) 699,780 Long-term debt, less current portion 388,597 (2,764 ) 385,833 Total liabilities and stockholders’ equity 702,544 (2,764 ) 699,780
Schedule of assets and liabilities measured at fair value on a recurring basis	Assets and liabilities measured at fair value on a recurring basis as of December 31, 2016 and March 31, 2016 are as follows (amounts in thousands): Carrying Value December 31, Fair Value December 31, Fair Value Measurement Using Carrying Value March 31, Fair Value March 31, Fair Value Measurement Using 2016 2016 Level 1 Level 2 (2) Level 3 2016 2016 Level 1 Level 2 (2) Level 3 Assets (Liabilities): Money markets (1) $ 719 $ 719 $ 719 $ — $ — $ 738 $ 738 $ 738 $ — $ — Total debt (386,226 ) (383,880 ) (353,441 ) (30,439 ) — (387,833 ) (284,261 ) (254,713 ) (29,548 ) — NEC TOKIN option, net (3) (24,100 ) (24,100 ) — — (24,100 ) (20,600 ) (20,600 ) — — (20,600 ) ___________________ (1) Included in the line item “Cash and cash equivalents” on the Condensed Consolidated Balance Sheets. (2) The valuation approach used to calculate fair value was a discounted cash flow based on the borrowing rate for each respective debt facility. (3) See Note 6 , “Investment in NEC TOKIN,” for a description of the NEC TOKIN option. The value of the option depends on the enterprise value of NEC TOKIN Corporation and its forecasted EBITDA over the duration of the option. The option has been valued using option pricing methods in a Monte Carlo simulation.
Summary of NEC TOKIN option valuation activity using significant unobservable inputs (Level 3)	The table below summarizes NEC TOKIN option valuation activity using significant unobservable inputs (Level 3) (amounts in thousands): March 31, 2016 $ (20,600 ) Change in value of NEC TOKIN option (3,500 ) December 31, 2016 $ (24,100 )
Schedule of components of inventories	Inventories are stated at the lower of cost or market. The components of inventories are as follows (amounts in thousands): December 31, 2016 March 31, 2016 Raw materials and supplies $ 68,233 $ 80,289 Work in process 48,545 46,631 Finished goods 53,709 58,060 170,487 184,980 Inventory reserves (15,968 ) (16,101 ) $ 154,519 $ 168,879

Debt (Tables)

Debt (Tables)	9 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Summary of Debt	A summary of debt is as follows (amounts in thousands): December 31, March 31, 10.5% Senior Notes, net (1) $ 352,345 $ 353,952 Revolving line of credit 33,881 33,881 Total debt 386,226 387,833 Current maturities — (2,000 ) Total long-term debt $ 386,226 $ 385,833 (1) As noted in Note 1, “Basis of Financial Statements Presentation,” ASU No. 2015-03, Interest - Imputation of Interest, was adopted as of April 1, 2016. As such, debt issuance cost, if any, is included within the respective debt balance. Amounts shown are net of premium and debt issuance costs of $0.7 million and $1.0 million as of December 31, 2016 and March 31, 2016 , respectively which reduce the 10.5% Senior Notes balance.
Schedule of line item Interest expense on the Condensed Consolidated Statements of Operations	The line item “Interest expense” on the Condensed Consolidated Statements of Operations for the quarters and nine-month periods ended December 31, 2016 and 2015 , consists of the following (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Contractual interest expense $ 9,693 $ 9,761 $ 29,091 $ 29,332 Capitalized interest (48 ) (163 ) (151 ) (439 ) Amortization of debt issuance costs 348 348 1,044 1,044 Amortization of debt (premium) discount (204 ) (188 ) (603 ) (554 ) Imputed interest on acquisition-related obligations 39 52 120 159 Interest expense on capital lease 90 42 250 134 Total interest expense $ 9,918 $ 9,852 $ 29,751 $ 29,676
Schedule of Line of Credit Facilities [Table Text Block]	The Company had the following activity for the nine-month period ended December 31, 2016 and resulting balances under the revolving line of credit (amounts in thousands, excluding percentages): March 31, Nine-Month Period Ended December 31, 2016 December 31, Outstanding Borrowings Additional Borrowings Repayments Outstanding Borrowings Rate (1) (2) Due Date U.S. Facility $ 19,881 $ — $ — $ 19,881 5.000 % December 19, 2019 Singapore Facility Singapore Borrowing 1 (3) 12,000 — — 12,000 3.500 % February 21, 2017 Singapore Borrowing 2 (3)(4) 2,000 — — 2,000 3.375 % January 9, 2017 Total Facilities $ 33,881 $ — $ — $ 33,881 ______________________________________________________________________________ (1) For U.S. borrowings, Base Rate plus 1.50% , as defined in the Loan and Security Agreement. (2) For Singapore borrowings, London Interbank Offer Rate (“LIBOR”), plus a spread of 2.50% as of December 31, 2016 . (3) The Company has the intent and ability to extend the due date on the Singapore borrowings. (4) In January 2017, the Company extended the due date to April 10, 2017 at 3.625% .

Restructuring Charges (Tables)

Restructuring Charges (Tables)	9 Months Ended
	Dec. 31, 2016
Restructuring and Related Activities [Abstract]
Summary of the expenses aggregated on the Condensed Consolidated Statements of Operations line item "Restructuring charges"	A summary of the expenses aggregated in the Condensed Consolidated Statements of Operations line item “Restructuring charges” in the quarters and nine-month periods ended December 31, 2016 and 2015 , is as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Personnel reduction costs $ (215 ) $ 795 $ 1,864 $ 1,905 Relocation and exit costs (154 ) 919 2,453 1,656 Restructuring charges $ (369 ) $ 1,714 $ 4,317 $ 3,561
Reconciliation of the beginning and ending liability balances for restructuring charges included in the line items Accrued expenses and Other non-current obligations on the Condensed Consolidated Balance Sheets	A reconciliation of the beginning and ending liability balances for restructuring charges included in the line items “Accrued expenses” and “Other non-current obligations” on the Condensed Consolidated Balance Sheets for the quarters and nine-month periods ended December 31, 2016 and 2015 is as follows (amounts in thousands): Quarter Ended December 31, 2016 Quarter Ended December 31, 2015 Personnel Reductions Manufacturing Relocations Personnel Reductions Manufacturing Relocations Beginning of period $ 2,101 $ 1,982 $ 2,279 $ — Costs charged to expense (215 ) (154 ) 795 919 Costs paid or settled (579 ) (832 ) (1,209 ) (919 ) Change in foreign exchange (46 ) — (43 ) — End of period $ 1,261 $ 996 $ 1,822 $ — Nine-Month Period Ended December 31, 2016 Nine-Month Period Ended December 31, 2015 Personnel Reductions Manufacturing Relocations Personnel Reductions Manufacturing Relocations Beginning of period $ 976 $ — $ 7,239 $ — Costs charged to expense 1,864 2,453 1,905 1,656 Costs paid or settled (1,510 ) (1,457 ) (7,492 ) (1,656 ) Change in foreign exchange (69 ) — 170 — End of period $ 1,261 $ 996 $ 1,822 $ —

Comprehensive Income (Loss) a25

Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	Dec. 31, 2016
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Schedule of changes in Accumulated Other Comprehensive Income (Loss)	Changes in Accumulated Other Comprehensive Income (Loss) (“AOCI”) for the quarters ended December 31, 2016 and 2015 include the following components (amounts in thousands): Foreign Currency Translation (1) Post-Retirement Defined Benefit Pension Plans, Net of Tax (2) Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) Foreign Exchange Contracts Net Accumulated Other Comprehensive Income (Loss) Balance at September 30, 2016 $ (17,347 ) $ 1,029 $ (14,834 ) $ (12,302 ) $ (2,073 ) $ (45,527 ) Other comprehensive income (loss) before reclassifications (10,773 ) — — 6,161 (2,146 ) (6,758 ) Amounts reclassified out of AOCI — 116 165 — 980 1,261 Other comprehensive income (loss) (10,773 ) 116 165 6,161 (1,166 ) (5,497 ) Balance at December 31, 2016 $ (28,120 ) $ 1,145 $ (14,669 ) $ (6,141 ) $ (3,239 ) $ (51,024 ) Foreign Currency Translation (1) Post-Retirement Defined Benefit Pension Plans, Net of Tax (2) Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) Foreign Exchange Contracts Net Accumulated Other Comprehensive Income (Loss) Balance at September 30, 2015 $ (10,733 ) $ 1,080 $ (19,951 ) $ (3,069 ) $ (2,714 ) $ (35,387 ) Other comprehensive income (loss) before reclassifications (6,121 ) — 6,663 143 (1,096 ) (411 ) Amounts reclassified out of AOCI — 96 247 — 1,768 2,111 Other comprehensive income (loss) (6,121 ) 96 6,910 143 672 1,700 Balance at December 31, 2015 $ (16,854 ) $ 1,176 $ (13,041 ) $ (2,926 ) $ (2,042 ) $ (33,687 ) Changes in AOCI for the nine-month periods ended December 31, 2016 and 2015 include the following components (amounts in thousands): Foreign Currency Translation (1) Post-Retirement Defined Benefit Pension Plans, Net of Tax (2) Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) Foreign Exchange Contracts Net Accumulated Other Comprehensive Income (Loss) Balance at March 31, 2016 $ (10,272 ) $ 1,114 $ (15,161 ) $ (6,739 ) $ (367 ) $ (31,425 ) Other comprehensive income (loss) before reclassifications (17,848 ) — — 598 (6,745 ) (23,995 ) Amounts reclassified out of AOCI — 31 492 — 3,873 4,396 Other comprehensive income (loss) (17,848 ) 31 492 598 (2,872 ) (19,599 ) Balance at December 31, 2016 $ (28,120 ) $ 1,145 $ (14,669 ) $ (6,141 ) $ (3,239 ) $ (51,024 ) Foreign Currency Translation (1) Post-Retirement Defined Benefit Pension Plans, Net of Tax (2) Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) Foreign Exchange Contracts Net Accumulated Other Comprehensive Income (Loss) Balance at March 31, 2015 $ (12,132 ) $ 1,159 $ (20,363 ) $ 1,537 $ 1,003 $ (28,796 ) Other comprehensive income (loss) before reclassifications (4,722 ) — 6,663 (4,463 ) (6,289 ) (8,811 ) Amounts reclassified out of AOCI — 17 659 — 3,244 3,920 Other comprehensive income (loss) (4,722 ) 17 7,322 (4,463 ) (3,045 ) (4,891 ) Balance at December 31, 2015 $ (16,854 ) $ 1,176 $ (13,041 ) $ (2,926 ) $ (2,042 ) $ (33,687 ) (1) Due primarily to the Company’s valuation allowance on deferred tax assets, there were no significant deferred tax effects associated with the cumulative currency translation gains and losses during the quarter and nine-month periods ended December 31, 2016 and 2015 . (2) Ending balance is net of tax of $2.0 million and $2.2 million as of December 31, 2016 and December 31, 2015 , respectively.

Investment in NEC TOKIN (Tables

Investment in NEC TOKIN (Tables)	9 Months Ended
	Dec. 31, 2016
Equity Method Investments and Joint Ventures [Abstract]
Reconciliation between NEC TOKIN's net loss and KEMET's equity investment loss	Summarized financial information for NEC TOKIN follows (amounts in thousands): December 31, March 31, Current assets $ 248,128 $ 240,427 Non-current assets 230,232 260,614 Current liabilities 160,648 179,360 Non-current liabilities 322,768 335,500 Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Sales $ 127,845 $ 111,594 $ 374,944 $ 343,686 Gross profit 28,886 24,610 82,487 74,333 Net income (loss) (1) 1,082 (17,867 ) 5,444 (10,606 ) (1) The significant changes between the periods were due to the additional accrual of anti-trust litigation loss recorded during the quarter ended December 31, 2015; see discussion below. A reconciliation between NEC TOKIN’s net income (loss) and KEC’s equity investment income (loss) follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 NEC TOKIN net income (loss) $ 1,082 $ (17,867 ) $ 5,444 $ (10,606 ) KEC’s economic interest % 34 % 34 % 34 % 34 % Equity income (loss) from NEC TOKIN before adjustments 368 (6,075 ) 1,851 (3,606 ) Adjustments: Amortization and depreciation (562 ) (494 ) (1,686 ) (1,118 ) Inventory profit elimination 61 64 106 (34 ) Equity income (loss) from NEC TOKIN $ (133 ) $ (6,505 ) $ 271 $ (4,758 ) A reconciliation between NEC TOKIN’s net assets and KEC’s investment in NEC TOKIN follows (amounts in thousands): December 31, March 31, Investment in NEC TOKIN $ 21,202 $ 20,334 Purchase price accounting basis adjustments: Property, plant and equipment (1) 3,014 3,365 Technology (1) (8,657 ) (10,134 ) Long-term debt (1) (1,238 ) (1,975 ) Goodwill (7,250 ) (7,555 ) Indemnity asset for legal investigation (8,500 ) (8,500 ) Inventory profit elimination (2) 265 371 Other (553 ) (604 ) KEC’s 34% economic interest in NEC TOKIN’s net assets $ (1,717 ) $ (4,698 ) (1) Amortized over the estimated lives. (2) Adjusted each period for any activity.
Schedule of Related Party Transactions	Summarized transactions between KEC and NEC TOKIN are as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 KEC’s sales to NEC TOKIN $ 4,814 $ 5,020 $ 13,096 $ 14,350 NEC TOKIN’s sales to KEMET 2,350 1,157 6,112 4,747 December 31, March 31, Accounts receivable $ 2,989 $ 5,220 Accounts payable 907 1,019 Management service agreement receivable (1) 638 748 (1) In accordance with the Stockholders’ Agreement, KEC entered into a management services agreement with NEC TOKIN to provide services for which KEC is being reimbursed.

Segment and Geographic Inform27

Segment and Geographic Information (Tables)	9 Months Ended
	Dec. 31, 2016
Segment Reporting [Abstract]
Schedule of business group's net sales, operating income (loss), depreciation and amortization expenses and sales by region	The following table reflects each business group’s net sales, operating income (loss), depreciation and amortization expenses and sales by region for the quarters and nine-month periods ended December 31, 2016 and 2015 (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Net sales: Solid Capacitors $ 141,555 $ 135,300 $ 426,140 $ 416,261 Film and Electrolytic 46,474 41,884 134,132 134,636 $ 188,029 $ 177,184 $ 560,272 $ 550,897 Operating income (loss) (1) (2): Solid Capacitors $ 37,264 $ 31,359 $ 107,753 $ 95,371 Film and Electrolytic 2,332 (1,770 ) (6,231 ) 1,159 Corporate (25,746 ) (21,096 ) (75,724 ) (72,807 ) $ 13,850 $ 8,493 $ 25,798 $ 23,723 Depreciation and amortization expense: Solid Capacitors $ 5,078 $ 5,293 $ 15,643 $ 16,227 Film and Electrolytic 2,560 3,031 8,111 8,901 Corporate 1,457 1,350 4,217 3,728 $ 9,095 $ 9,674 $ 27,971 $ 28,856 __________________ (1) Restructuring charges included in Operating income (loss) are as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Restructuring charges: Solid Capacitors $ (128 ) $ 754 $ 566 $ 1,556 Film and Electrolytic (243 ) 987 3,421 1,524 Corporate 2 (27 ) 330 481 $ (369 ) $ 1,714 $ 4,317 $ 3,561 (2) Write down of long-lived assets included in Operating income (loss) are as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Write down of Long-lived Assets Solid Capacitors $ — $ — $ 2,076 $ — Film and Electrolytic — — 4,117 — $ — $ — $ 6,193 $ — ___________________ Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Sales by region: North and South America (“Americas”) $ 54,976 $ 56,411 $ 166,858 $ 170,525 Europe, Middle East, Africa (“EMEA”) 55,765 52,453 176,298 173,468 Asia and Pacific Rim (“APAC”) 77,288 68,320 217,116 206,904 $ 188,029 $ 177,184 $ 560,272 $ 550,897

Defined Benefit Pension and O28

Defined Benefit Pension and Other Postretirement Benefit Plans (Tables)	9 Months Ended
	Dec. 31, 2016
Compensation and Retirement Disclosure [Abstract]
Schedule of components of net periodic benefit (income) costs relating to pension and other postretirement benefit plans	The components of net periodic benefit (income) costs relating to the Company’s pension and other postretirement benefit plans are as follows for the quarters ended December 31, 2016 and 2015 (amounts in thousands): Pension Post-retirement Benefit Plan Quarters Ended December 31, Quarters Ended December 31, 2016 2015 2016 2015 Net service cost $ 347 $ 404 $ — $ — Interest cost 358 338 1 3 Expected return on net assets (94 ) (105 ) — — Amortization: Actuarial (gain) loss 115 197 (71 ) (64 ) Prior service cost 21 15 — — Total net periodic benefit (income) costs $ 747 $ 849 $ (70 ) $ (61 ) The components of net periodic benefit (income) costs relating to the Company’s pension and other postretirement benefit plans are as follows for the nine-month periods ended December 31, 2016 and 2015 (amounts in thousands): Pension Post-retirement Benefit Plan Nine-Month Periods Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Net service cost $ 1,040 $ 1,514 $ — $ — Interest cost 1,076 1,013 9 14 Expected return on net assets (283 ) (315 ) — — Amortization: Actuarial (gain) loss 345 591 (155 ) (143 ) Prior service cost 64 44 — — Total net periodic benefit (income) costs $ 2,242 $ 2,847 $ (146 ) $ (129 )

Stock-based Compensation (Table

Stock-based Compensation (Tables)	9 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity	On May 18, 2016, the Company granted RSUs under the 2017/2018 LTIP with a grant date fair value of $2.46 that vests as follows (amounts in thousands): Shares May 18, 2017 202 May 18, 2018 202 May 18, 2019 209 Total shares granted 613 The following is the vesting schedule of RSUs under each respective LTIP, which vested during the nine-month period ended December 31, 2016 (shares in thousands): 2016/2017 2015/2016 2014/2015 Time-based award vested 187 111 130 Performance-based award vested — 103 73 Restricted stock activity, excluding the LTIP activity discussed above, for the nine-month period ended December 31, 2016 is as follows (amounts in thousands except fair value): Shares Weighted- Non-vested restricted stock at March 31, 2016 1,430 $ 3.51 Granted 381 4.82 Vested (328 ) 3.06 Forfeited (20 ) 3.19 Non-vested restricted stock at December 31, 2016 1,463 $ 5.21
Schedule of the compensation expense (recovery) associated with stock-based compensation	The compensation expense associated with stock-based compensation for the quarters ended December 31, 2016 and 2015 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands): Quarter Ended December 31, 2016 Quarter Ended December 31, 2015 Stock Options Restricted Stock LTIPs Stock Options Restricted Stock LTIPs Cost of sales $ 3 $ 127 $ 178 $ 11 $ 130 $ 127 Selling, general and administrative expenses 4 379 402 11 340 474 Research and development — 5 41 1 6 54 Total $ 7 $ 511 $ 621 $ 23 $ 476 $ 655 The compensation expense associated with stock-based compensation for the nine-month periods ended December 31, 2016 and 2015 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands): Nine-Month Period Ended December 31, 2016 Nine-Month Period Ended December 31, 2015 Stock Options Restricted Stock LTIPs Stock Options Restricted Stock LTIPs Cost of sales $ 21 $ 415 $ 557 $ 72 $ 444 $ 624 Selling, general and administrative expenses 20 1,072 1,232 79 1,033 1,365 Research and development 1 15 138 4 17 123 Total $ 42 $ 1,502 $ 1,927 $ 155 $ 1,494 $ 2,112

Basic and Diluted Net Income 30

Basic and Diluted Net Income (Loss) Per Common Share (Tables)	9 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Schedule of basic EPS and diluted EPS	The following table presents basic earnings per share (“EPS”) and diluted EPS (amounts in thousands, except per share data): Quarters Ended December 31, Nine-Month Periods Ended 2016 2015 2016 2015 Numerator: Net income (loss) $ 12,278 $ (8,600 ) $ (4,925 ) $ (38,456 ) Denominator: Weighted-average shares outstanding: Basic 46,606 46,081 46,469 45,953 Assumed conversion of employee stock grants 2,122 — — — Assumed conversion of warrants 6,568 — — — Diluted 55,296 46,081 46,469 45,953 Net income (loss) per basic share $ 0.26 $ (0.19 ) $ (0.11 ) $ (0.84 ) Net income (loss) per diluted share $ 0.22 $ (0.19 ) $ (0.11 ) $ (0.84 )
Schedule of common stock equivalents that could potentially dilute net income (loss) per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been antidilutive	Common stock equivalents that could potentially dilute net income (loss) per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been anti-dilutive, are as follows (amounts in thousands): Quarters Ended December 31, Nine-Month Periods Ended December 31, 2016 2015 2016 2015 Assumed conversion of employee stock grants 800 3,257 2,760 3,247 Assumed conversion of warrants — 5,168 5,913 5,261

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	The balance sheet classifications and fair value of derivative instruments as of December 31, 2016 are as follows (amounts in thousands): Fair Value of Derivative Instruments (1) Accrued expenses $ 3,240 ______________________________________________________________________________ (1) Fair Value measured using Level 2 inputs by adjusting the market spot rate by forward points, based on the date of the contract. The spot rates and forward points used are based on an average rate from an actively traded market.
Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]	The impact on the Consolidated Statement of Operations for the quarter and nine-month period ended December 31, 2016 are as follows (amounts in thousands): Impact of Foreign Exchange Contracts on Condensed Consolidated Statement of Operations Statement Caption Quarter Ended December 31, 2016 Nine-Month Period Ended December 31, 2016 Net Sales $ — $ — Operating costs and expenses: Cost of sales (980 ) (3,873 ) Total operating costs and expenses (980 ) (3,873 ) Operating income (loss) $ (980 ) $ (3,873 )

Condensed Consolidating Finan32

Condensed Consolidating Financial Statements (Tables)	9 Months Ended
	Dec. 31, 2016
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Condensed Consolidating Balance Sheet	Condensed Consolidating Balance Sheet March 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated ASSETS Current assets: Cash and cash equivalents $ 640 $ 36,209 $ 28,155 $ — $ 65,004 Accounts receivable, net — 41,025 52,143 — 93,168 Intercompany receivable 30,210 132,523 170,224 (332,957 ) — Inventories, net — 113,289 55,590 — 168,879 Prepaid expenses and other 3,325 12,161 12,974 (2,964 ) 25,496 Total current assets 34,175 335,207 319,086 (335,921 ) 352,547 Property and equipment, net 255 93,936 147,648 — 241,839 Goodwill — 40,294 — — 40,294 Intangible assets, net — 27,252 6,049 — 33,301 Investment in NEC TOKIN — 20,334 — — 20,334 Investments in subsidiaries 382,108 429,723 93,359 (905,190 ) — Deferred income taxes — 800 7,597 — 8,397 Other assets — 2,452 616 — 3,068 Long-term intercompany receivable 67,500 41,428 1,088 (110,016 ) — Total assets $ 484,038 $ 991,426 $ 575,443 $ (1,351,127 ) $ 699,780 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 2,000 $ — $ — $ — $ 2,000 Accounts payable 20 34,618 36,343 — 70,981 Intercompany payable 280 275,498 57,179 (332,957 ) — Accrued expenses 17,305 11,807 21,208 — 50,320 Income taxes payable — 2,983 434 (2,964 ) 453 Total current liabilities 19,605 324,906 115,164 (335,921 ) 123,754 Long-term debt, less current portion 351,952 19,881 14,000 — 385,833 Other non-current obligations — 25,797 49,095 — 74,892 Deferred income taxes — 2,242 578 — 2,820 Long-term intercompany payable — 67,500 42,516 (110,016 ) — Stockholders’ equity 112,481 551,100 354,090 (905,190 ) 112,481 Total liabilities and stockholders’ equity $ 484,038 $ 991,426 $ 575,443 $ (1,351,127 ) $ 699,780 Condensed Consolidating Balance Sheet December 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated ASSETS Current assets: Cash and cash equivalents $ 729 $ 46,038 $ 40,589 $ — $ 87,356 Accounts receivable, net — 26,500 56,019 — 82,519 Intercompany receivable 32,874 195,280 149,763 (377,917 ) — Inventories, net — 102,559 51,960 — 154,519 Prepaid expenses and other 3,325 11,976 11,698 (2,964 ) 24,035 Total current assets 36,928 382,353 310,029 (380,881 ) 348,429 Property and equipment, net 498 81,692 129,737 — 211,927 Goodwill — 40,294 — — 40,294 Intangible assets, net — 25,020 5,184 — 30,204 Investment in NEC TOKIN — 21,202 — — 21,202 Investments in subsidiaries 394,561 427,702 93,359 (915,622 ) — Deferred income taxes — 1,045 6,723 — 7,768 Other assets 27 1,779 906 — 2,712 Long-term intercompany receivable 62,496 38,356 1,089 (101,941 ) — Total assets $ 494,510 $ 1,019,443 $ 547,027 $ (1,398,444 ) $ 662,536 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable 40 30,601 31,706 — 62,347 Intercompany payable 42,935 270,738 64,244 (377,917 ) — Accrued expenses 8,743 19,334 18,341 — 46,418 Income taxes payable — 3,007 1,025 (2,964 ) 1,068 Total current liabilities 51,718 323,680 115,316 (380,881 ) 109,833 Long-term debt, less current portion 352,345 19,881 14,000 — 386,226 Other non-current obligations — 27,399 45,305 — 72,704 Deferred income taxes — 2,556 770 — 3,326 Long-term intercompany payable — 62,496 39,445 (101,941 ) — Stockholders’ equity 90,447 583,431 332,191 (915,622 ) 90,447 Total liabilities and stockholders’ equity $ 494,510 $ 1,019,443 $ 547,027 $ (1,398,444 ) $ 662,536
Condensed Consolidating Statement of Operations	Condensed Consolidating Statement of Operation For the Nine-Month Period Ended December 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Net sales $ — $ 642,253 $ 519,814 $ (601,795 ) $ 560,272 Operating costs and expenses: Cost of sales 1,023 499,922 485,391 (562,337 ) 423,999 Selling, general and administrative expenses 31,471 52,796 33,743 (39,459 ) 78,551 Research and development 228 13,581 7,298 — 21,107 Restructuring charges — 3,125 1,192 — 4,317 Write down of long-lived assets — 4,585 1,608 — 6,193 Net (gain) loss on sales and disposals of assets (292 ) 1,132 (533 ) — 307 Total operating costs and expenses 32,430 575,141 528,699 (601,796 ) 534,474 Operating income (loss) (32,430 ) 67,112 (8,885 ) 1 25,798 Non-operating (income) expense: Interest income — 3 (17 ) — (14 ) Interest expense 28,214 1,161 376 — 29,751 Change in value of NEC TOKIN option — 3,500 — — 3,500 Other (income) expense, net (28,672 ) 29,556 (7,567 ) — (6,683 ) Equity in earnings of subsidiaries (27,047 ) — — 27,047 — Income (loss) before income taxes and equity income (loss) from NEC TOKIN (4,925 ) 32,892 (1,677 ) (27,046 ) (756 ) Income tax expense (benefit) — 94 4,346 — 4,440 Income (loss) before equity income (loss) from NEC TOKIN (4,925 ) 32,798 (6,023 ) (27,046 ) (5,196 ) Equity income (loss) from NEC TOKIN — 271 — — 271 Net income (loss) $ (4,925 ) $ 33,069 $ (6,023 ) $ (27,046 ) $ (4,925 ) Condensed Consolidating Statement of Operations For the Nine-Month Period Ended December 31, 2015 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Net sales $ — $ 655,808 $ 527,604 $ (632,515 ) $ 550,897 Operating costs and expenses: Cost of sales 931 528,352 490,621 (590,274 ) 429,630 Selling, general and administrative expenses 27,028 56,197 34,672 (42,241 ) 75,656 Research and development 26 12,834 5,700 — 18,560 Restructuring charges — 2,182 1,379 — 3,561 Net (gain) loss on sales and disposals of assets (7 ) (1,101 ) 875 — (233 ) Total operating costs and expenses 27,978 598,464 533,247 (632,515 ) 527,174 Operating income (loss) (27,978 ) 57,344 (5,643 ) — 23,723 Non-operating (income) expense: Interest income — — (10 ) — (10 ) Interest expense 28,395 865 416 — 29,676 Change in value of NEC TOKIN option — 26,300 — — 26,300 Other (income) expense, net (25,484 ) 25,065 (2,076 ) — (2,495 ) Equity in earnings of subsidiaries 7,567 — — (7,567 ) — Income (loss) before income taxes and equity income (loss) from NEC TOKIN (38,456 ) 5,114 (3,973 ) 7,567 (29,748 ) Income tax expense (benefit) — (320 ) 4,270 — 3,950 Income (loss) before equity income (loss) from NEC TOKIN (38,456 ) 5,434 (8,243 ) 7,567 (33,698 ) Equity income (loss) from NEC TOKIN — (4,758 ) — — (4,758 ) Net income (loss) $ (38,456 ) $ 676 $ (8,243 ) $ 7,567 $ (38,456 ) Condensed Consolidating Statement of Operations For the Quarter Ended December 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Net sales $ — $ 211,214 $ 179,921 $ (203,106 ) $ 188,029 Operating costs and expenses: Cost of sales 257 163,260 166,866 (189,691 ) 140,692 Selling, general and administrative expenses 11,695 16,590 11,795 (13,415 ) 26,665 Research and development 72 4,708 2,279 — 7,059 Restructuring charges — (466 ) 97 — (369 ) Write down of long-lived assets — (1,608 ) 1,608 — — Net (gain) loss on sales and disposals of assets (7 ) 109 30 — 132 Total operating costs and expenses 12,017 182,593 182,675 (203,106 ) 174,179 Operating income (loss) (12,017 ) 28,621 (2,754 ) — 13,850 Non-operating (income) expense: Interest income — — (5 ) — (5 ) Interest expense 9,395 383 140 — 9,918 Change in value of NEC TOKIN option — (6,900 ) — — (6,900 ) Other (income) expense, net (10,479 ) 11,671 (4,576 ) — (3,384 ) Equity in earnings of subsidiaries (23,211 ) — — 23,211 — Income (loss) before income taxes and equity income (loss) from NEC TOKIN 12,278 23,467 1,687 (23,211 ) 14,221 Income tax expense (benefit) — 37 1,773 — 1,810 Income (loss) before equity income (loss) from NEC TOKIN 12,278 23,430 (86 ) (23,211 ) 12,411 Equity income (loss) from NEC TOKIN — (133 ) — — (133 ) Net income (loss) $ 12,278 $ 23,297 $ (86 ) $ (23,211 ) $ 12,278 Condensed Consolidating Statement of Operations For the Quarter Ended December 31, 2015 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Net sales $ — $ 211,268 $ 170,531 $ (204,615 ) $ 177,184 Operating costs and expenses: Cost of sales 232 173,368 156,669 (191,833 ) 138,436 Selling, general and administrative expenses 8,306 16,207 10,547 (12,782 ) 22,278 Research and development 79 4,232 1,823 — 6,134 Restructuring charges — 726 988 — 1,714 Net (gain) loss on sales and disposals of assets — (348 ) 477 — 129 Total operating costs and expenses 8,617 194,185 170,504 (204,615 ) 168,691 Operating income (loss) (8,617 ) 17,083 27 — 8,493 Non-operating (income) expense: Interest income — — (4 ) — (4 ) Interest expense 9,461 267 124 — 9,852 Change in value of NEC TOKIN option — (700 ) — — (700 ) Other (income) expense, net (7,931 ) 7,997 (1,386 ) — (1,320 ) Equity in earnings of subsidiaries (1,547 ) — — 1,547 — Income (loss) before income taxes and equity income (loss) from NEC TOKIN (8,600 ) 9,519 1,293 (1,547 ) 665 Income tax expense (benefit) — 44 2,716 — 2,760 Income (loss) before equity income (loss) from NEC TOKIN (8,600 ) 9,475 (1,423 ) (1,547 ) (2,095 ) Equity income (loss) from NEC TOKIN — (6,505 ) — — (6,505 ) Net income (loss) $ (8,600 ) $ 2,970 $ (1,423 ) $ (1,547 ) $ (8,600 )
Condensed Statement of Comprehensive Income	Condensed Consolidating Statements of Comprehensive Income (Loss) For the Quarter Ended December 31, 2015 (Unaudited) Comprehensive income (loss) $ (10,474 ) $ 4,604 $ 517 $ (1,547 ) $ (6,900 ) Condensed Consolidating Statements of Comprehensive Income (Loss) For the Nine-Month Period Ended December 31, 2015 (Unaudited) Comprehensive income (loss) $ (37,698 ) $ (7,109 ) $ (6,107 ) $ 7,567 $ (43,347 ) Condensed Consolidating Statements of Comprehensive Income (Loss) Quarter Ended December 31, 2016 (Unaudited) Comprehensive income (loss) $ 8,602 $ 29,828 $ (8,438 ) $ (23,211 ) $ 6,781 Condensed Consolidating Statements of Comprehensive Income (Loss) For the Nine-Month Period Ended December 31, 2016 (Unaudited) Comprehensive income (loss) $ (9,929 ) $ 32,331 $ (19,880 ) $ (27,046 ) $ (24,524 )
Condensed Consolidating Statement of Cash Flows	Condensed Consolidating Statement of Cash Flows For the Nine-Month Period Ended December 31, 2016 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Sources (uses) of cash and cash equivalents Net cash provided by (used in) operating activities $ 2,942 $ 14,962 $ 24,240 $ — $ 42,144 Investing activities: Capital expenditures — (5,133 ) (9,878 ) — (15,011 ) Net cash used in investing activities — (5,133 ) (9,878 ) — (15,011 ) Financing activities: Payments of long-term obligations (1,870 ) — (558 ) — (2,428 ) Proceeds from exercise of stock options 69 — — — 69 Purchase of treasury stock (1,052 ) — — — (1,052 ) Net cash provided by (used in) financing activities (2,853 ) — (558 ) — (3,411 ) Net increase (decrease) in cash and cash equivalents 89 9,829 13,804 — 23,722 Effect of foreign currency fluctuations on cash — — (1,370 ) — (1,370 ) Cash and cash equivalents at beginning of fiscal period 640 36,209 28,155 — 65,004 Cash and cash equivalents at end of fiscal period $ 729 $ 46,038 $ 40,589 $ — $ 87,356 Condensed Consolidating Statements of Cash Flows For the Nine-Month Period Ended December 31, 2015 (Unaudited) Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Reclassifications and Eliminations Consolidated Sources (uses) of cash and cash equivalents Net cash provided by (used in) operating activities $ 691 $ (8,085 ) $ 6,837 $ — $ (557 ) Investing activities: Capital expenditures — (6,221 ) (7,899 ) — (14,120 ) Proceeds from sale of assets — 247 651 — 898 Acquisitions, net of cash received — (2,892 ) — — (2,892 ) Net cash used in investing activities — (8,866 ) (7,248 ) — (16,114 ) Financing activities: Proceeds from revolving line of credit — 8,000 2,000 — 10,000 Payments of revolving line of credit — (5,500 ) — — (5,500 ) Payments of long-term obligations — — (481 ) — (481 ) Purchase of treasury stock (691 ) — — — (691 ) Net cash provided by (used in) financing activities (691 ) 2,500 1,519 — 3,328 Net increase (decrease) in cash and cash equivalents — (14,451 ) 1,108 — (13,343 ) Effect of foreign currency fluctuations on cash — — 139 — 139 Cash and cash equivalents at beginning of fiscal period 640 33,094 22,628 — 56,362 Cash and cash equivalents at end of fiscal period $ 640 $ 18,643 $ 23,875 $ — $ 43,158

Basis of Financial Statement 33

Basis of Financial Statement Presentation (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2016
Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]
Other assets					$ 3,068,000
Total assets	$ 662,536,000		$ 662,536,000		699,780,000
Long-term debt, less current portion	386,226,000		386,226,000		385,833,000
Total liabilities and stockholders’ equity	662,536,000		662,536,000		699,780,000
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Money markets	719,000		719,000		738,000
Total debt	(386,226,000)		(386,226,000)		(387,833,000)
NEC TOKIN option, net	(24,100,000)		(24,100,000)		(20,600,000)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Change in value of NEC TOKIN option	6,900,000	$ 700,000	(3,500,000)	$ (26,300,000)
Inventory, Gross [Abstract]
Raw materials and supplies	68,233,000		68,233,000		80,289,000
Work in process	48,545,000		48,545,000		46,631,000
Finished goods	53,709,000		53,709,000		58,060,000
Inventory, gross	170,487,000		170,487,000		184,980,000
Inventory reserves	(15,968,000)		(15,968,000)		(16,101,000)
Inventories, net	$ 154,519,000		$ 154,519,000		$ 168,879,000
Warrant
Number of shares subject to a warrant held by K Equity, LLC	8,416,815		8,416,815		8,416,815
Revenue Recognition
Maximum Percentage of Purchased Inventory that Can be Returned by Distributor			6.00%
Period of product warranty			1 year
Warranty costs as a percentage of net sales, maximum	1.00%	1.00%	1.00%	1.00%
Recurring
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Total debt, fair value	$ (383,880,000)		$ (383,880,000)		$ (284,261,000)
NEC TOKIN option, net, fair value	(24,100,000)		(24,100,000)		(20,600,000)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Beginning balance			(20,600,000)
Change in value of NEC TOKIN option			(3,500,000)
Ending balance	(24,100,000)		(24,100,000)
Recurring | Money Market Funds [Member]
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Money markets, fair value	719,000		719,000		738,000
Recurring | Level 1
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Total debt, fair value	(353,441,000)		(353,441,000)		(254,713,000)
Recurring | Level 1 | Money Market Funds [Member]
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Money markets, fair value	719,000		719,000		738,000
Recurring | Level 2
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Total debt, fair value	(30,439,000)		(30,439,000)		(29,548,000)
Recurring | Level 2 | Money Market Funds [Member]
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Money markets, fair value	0		0		0
Recurring | Level 3
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Total debt, fair value	0		0		0
NEC TOKIN option, net, fair value	(24,100,000)		(24,100,000)		(20,600,000)
Recurring | Level 3 | Money Market Funds [Member]
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Money markets, fair value	$ 0		$ 0		0
Restatement Adjustment [Member] | Accounting Standards Update 2015-03 [Member]
Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]
Other assets					(2,764,000)
Total assets					(2,764,000)
Long-term debt, less current portion					(2,764,000)
Total liabilities and stockholders’ equity					(2,764,000)
Scenario, Previously Reported [Member]
Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]
Other assets					5,832,000
Total assets					702,544,000
Long-term debt, less current portion					388,597,000
Total liabilities and stockholders’ equity					702,544,000
New Accounting Pronouncement, Early Adoption, Effect [Member] | Retained Earnings [Member] | Accounting Standards Update 2016-09 [Member]
Fair Value Measurement
Cumulative effect of new accounting principle in period of adoption					$ 130,000

Debt (Details)

Debt (Details) - USD ($)	3 Months Ended				9 Months Ended
	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Jan. 09, 2017	May 02, 2016
Debt
Document Period End Date					Dec. 31, 2016
Debt, Long-term and Short-term, Combined Amount [Abstract]
Total debt	$ 386,226,000	$ 387,833,000			$ 386,226,000
Revolving line of credit	33,881,000	33,881,000			33,881,000
Current maturities	0	(2,000,000)			0
Total long-term debt	386,226,000	385,833,000			386,226,000
Amortization of financing and debt discount		(1,000,000)			(700,000)
Interest expense
Contractual interest expense	9,693,000		$ 9,761,000		29,091,000	$ 29,332,000
Capitalized interest	(48,000)		(163,000)		(151,000)	(439,000)
Amortization of debt issuance costs	348,000		348,000		1,044,000	1,044,000
Amortization of debt (premium) discount	(204,000)		(188,000)		(603,000)	(554,000)
Imputed interest on acquisition-related obligations	39,000		52,000		120,000	159,000
Interest expense on capital lease	90,000		42,000		250,000	134,000
Total interest expense	9,918,000		$ 9,852,000		29,751,000	29,676,000
Line of Credit Facility [Abstract]
Additional Borrowings					0
Repayments					0	$ 5,500,000
10.5% Senior Notes, net [Member]
Debt, Long-term and Short-term, Combined Amount [Abstract]
Total debt	352,345,000	353,952,000			$ 352,345,000
Amortization of financing and debt discount	$ (655,000)			$ (1,047,000)
Line of Credit Facility [Abstract]
Rate	10.50%				10.50%
Long-term Debt, Unclassified [Abstract]
Repayments of debt					$ 2,000,000
Long-term debt outstanding	$ 353,000,000	354,999,000			353,000,000
Interest payable	6,178,000	15,500,000			6,178,000
Revolving Credit Facility [Member]
Line of Credit Facility [Abstract]
Current borrowing capacity								$ 65,000,000
Remaining borrowing capacity	31,100,000				31,100,000
Domestic Line of Credit [Member]
Debt, Long-term and Short-term, Combined Amount [Abstract]
Revolving line of credit	$ 19,881,000	19,881,000			19,881,000
Line of Credit Facility [Abstract]
Additional Borrowings					0
Repayments					$ 0
Domestic Line of Credit [Member] | Base Rate [Member]
Line of Credit Facility [Abstract]
Rate	5.00%				5.00%
Foreign Line of Credit [Member]
Line of Credit Facility [Abstract]
Additional Borrowings					$ 0
Foreign Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Abstract]
Basis spread on variable rate					2.50%
Foreign Line of Credit [Member] | Letter of Credit One [Member]
Debt, Long-term and Short-term, Combined Amount [Abstract]
Revolving line of credit	$ 12,000,000	12,000,000			$ 12,000,000
Foreign Line of Credit [Member] | Letter of Credit One [Member] | London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Abstract]
Rate	3.50%				3.50%
Foreign Line of Credit [Member] | Letter of Credit Two [Member]
Debt, Long-term and Short-term, Combined Amount [Abstract]
Revolving line of credit	$ 2,000,000	$ 2,000,000			$ 2,000,000
Foreign Line of Credit [Member] | Letter of Credit Two [Member] | London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Abstract]
Rate	3.375%				3.375%
US Facility [Member] | Base Rate [Member]
Line of Credit Facility [Abstract]
Basis spread on variable rate					1.50%
Subsequent Event [Member] | Foreign Line of Credit [Member] | Letter of Credit Two [Member] | London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Abstract]
Rate							3.625%

Impairment charges (Details)

Impairment charges (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Write down of long-lived assets	$ 0	$ 6,200	$ 0	$ 6,193	$ 0
Film and Electrolytic
Property, Plant and Equipment [Line Items]
Write down of long-lived assets		4,100
Impairment of long-lived assets to be disposed of		3,000
Impairment of Intangible assets		1,100
Solid Capacitors
Property, Plant and Equipment [Line Items]
Write down of long-lived assets		$ 2,100
Solid Capacitors | Facility Closing [Member]
Property, Plant and Equipment [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	100			100
Restructuring and related cost, expected cost remaining	$ 1,100			$ 1,100

Restructuring Charges (Details)

Restructuring Charges (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 31, 2016USD ($)employee	Dec. 31, 2015USD ($)	Dec. 31, 2014employee	Dec. 31, 2016USD ($)employee	Dec. 31, 2015USD ($)
Restructuring Charges
Document Period End Date				Dec. 31, 2016
Restructuring charges	$ (369)	$ 1,714		$ 4,317	$ 3,561
Reconciliation of restructuring liability
Costs charged to expense	(369)	1,714		4,317	3,561
Employee Severance
Restructuring Charges
Restructuring charges	$ (215)	795		$ 1,864	1,905
Expected number of positions eliminated | employee			50
Number of positions eliminated, inception to date | employee	24			24
Reconciliation of restructuring liability
Beginning of period	$ 2,101	2,279		$ 976	7,239
Costs charged to expense	(215)	795		1,864	1,905
Costs paid or settled	(579)	(1,209)		(1,510)	(7,492)
Change in foreign exchange	(46)	(43)		(69)	170
End of period	1,261	1,822		1,261	1,822
Employee Severance | Tennessee
Restructuring Charges
Restructuring charges				400
Reconciliation of restructuring liability
Costs charged to expense				400
Employee Severance | Mexico | Solid Capacitors
Restructuring Charges
Restructuring charges		100		300	900
Reconciliation of restructuring liability
Costs charged to expense		100		300	900
Employee Severance | Mexico | K-Salt
Restructuring Charges
Restructuring charges				100
Reconciliation of restructuring liability
Costs charged to expense				100
Employee Severance | Victoria Mexico [Member] | Solid Capacitors
Restructuring Charges
Restructuring charges		500
Reconciliation of restructuring liability
Costs charged to expense		500
Employee Severance | Florida
Restructuring Charges
Restructuring charges				300
Reconciliation of restructuring liability
Costs charged to expense				300
Employee Severance | England
Restructuring Charges
Restructuring charges				200
Reconciliation of restructuring liability
Costs charged to expense				200
Employee Severance | Sweden
Restructuring Charges
Restructuring charges				300
Reconciliation of restructuring liability
Costs charged to expense				300
Employee Severance | Europe
Restructuring Charges
Restructuring charges				300	400
Reconciliation of restructuring liability
Costs charged to expense				300	400
Employee Severance | Italy
Restructuring Charges
Restructuring accrual adjustment					(1,200)
Employee Severance | Europe and North America
Restructuring Charges
Restructuring charges		100			600
Reconciliation of restructuring liability
Costs charged to expense		100			600
Employee Severance | China | Film and Electrolytic
Restructuring Charges
Restructuring charges					600
Reconciliation of restructuring liability
Costs charged to expense					600
Manufacturing Relocation
Restructuring Charges
Restructuring charges	(154)	919		2,453	1,656
Reconciliation of restructuring liability
Beginning of period	1,982	0		0	0
Costs charged to expense	(154)	919		2,453	1,656
Costs paid or settled	(832)	(919)		(1,457)	(1,656)
Change in foreign exchange	0	0		0	0
End of period	996	$ 0		996	$ 0
Manufacturing Relocation | Film and Electrolytic
Restructuring Charges
Restructuring charges	100			400
Reconciliation of restructuring liability
Costs charged to expense	100			400
Manufacturing Relocation | Tennessee
Restructuring Charges
Restructuring charges				1,900
Restructuring accrual adjustment	(300)
Reconciliation of restructuring liability
Costs charged to expense				1,900
Manufacturing Relocation | Mexico | K-Salt
Restructuring Charges
Restructuring charges	100			100
Reconciliation of restructuring liability
Costs charged to expense	$ 100			100
Manufacturing Relocation | South Carolina
Restructuring Charges
Restructuring charges				100
Reconciliation of restructuring liability
Costs charged to expense				$ 100

Comprehensive Income (Loss) a37

Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Changes in accumulated other comprehensive income (loss)
Balance at the beginning of the period			$ 112,481
Balance at the end of the period	$ 90,447		90,447
Net Accumulated Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income (loss)
Balance at the beginning of the period	(45,527)	$ (35,387)	(31,425)	$ (28,796)
Other comprehensive income (loss) before reclassifications	(6,758)	(411)	(23,995)	(8,811)
Amounts reclassified out of AOCI	1,261	2,111	4,396	3,920
Other comprehensive income (loss)	(5,497)	1,700	(19,599)	(4,891)
Balance at the end of the period	(51,024)	(33,687)	(51,024)	(33,687)
Foreign Currency Translation
Changes in accumulated other comprehensive income (loss)
Balance at the beginning of the period	(17,347)	(10,733)	(10,272)	(12,132)
Other comprehensive income (loss) before reclassifications	(10,773)	(6,121)	(17,848)	(4,722)
Other comprehensive income (loss)	(10,773)	(6,121)	(17,848)	(4,722)
Balance at the end of the period	(28,120)	(16,854)	(28,120)	(16,854)
Post-Retirement Benefit Plan Adjustments
Changes in accumulated other comprehensive income (loss)
Balance at the beginning of the period	1,029	1,080	1,114	1,159
Amounts reclassified out of AOCI	116	96	31	17
Other comprehensive income (loss)	116	96	31	17
Balance at the end of the period	1,145	1,176	1,145	1,176
Defined Benefit Pension Plans, Net of Tax
Changes in accumulated other comprehensive income (loss)
Balance at the beginning of the period	(14,834)	(19,951)	(15,161)	(20,363)
Other comprehensive income (loss) before reclassifications		6,663		6,663
Amounts reclassified out of AOCI	165	247	492	659
Other comprehensive income (loss)	165	6,910	492	7,322
Balance at the end of the period	(14,669)	(13,041)	(14,669)	(13,041)
Accumulated tax expense (benefit)			2,000	2,200
Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income (loss)
Balance at the beginning of the period	(12,302)	(3,069)	(6,739)	1,537
Other comprehensive income (loss) before reclassifications	6,161	143	598	(4,463)
Other comprehensive income (loss)	6,161	143	598	(4,463)
Balance at the end of the period	(6,141)	(2,926)	(6,141)	(2,926)
Foreign Exchange Contracts
Changes in accumulated other comprehensive income (loss)
Balance at the beginning of the period	(2,073)	(2,714)	(367)	1,003
Other comprehensive income (loss) before reclassifications	(2,146)	(1,096)	(6,745)	(6,289)
Amounts reclassified out of AOCI	980	1,768	3,873	3,244
Other comprehensive income (loss)	(1,166)	672	(2,872)	(3,045)
Balance at the end of the period	$ (3,239)	$ (2,042)	$ (3,239)	$ (2,042)

Investment in NEC TOKIN - Stock

Investment in NEC TOKIN - Stock Purchase Agreement (Details) $ in Thousands	Feb. 01, 2013USD ($)director_position	Dec. 31, 2016USD ($)number_of_times	Dec. 31, 2015USD ($)	Apr. 30, 2015number_of_times	Dec. 31, 2016USD ($)number_of_times	Dec. 31, 2015USD ($)	Mar. 31, 2016USD ($)	Mar. 12, 2012
Schedule of Equity Method Investments [Line Items]
Change in value of NEC TOKIN option		$ 6,900	$ 700		$ (3,500)	$ (26,300)
Derivative Assets (Liabilities), at Fair Value, Net		$ (24,100)			(24,100)		$ (20,600)
Recurring
Schedule of Equity Method Investments [Line Items]
Change in value of NEC TOKIN option					$ (3,500)
Senior Notes [Member]
Schedule of Equity Method Investments [Line Items]
Rate		10.50%			10.50%
NEC TOKIN Corporation [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage		34.00%	34.00%		34.00%	34.00%
NEC TOKIN Corporation [Member] | Stockholders Agreement [Member]
Schedule of Equity Method Investments [Line Items]
Number of Director Positions | director_position	7
NEC TOKIN Corporation [Member] | Put Option [Member]
Schedule of Equity Method Investments [Line Items]
Derivative Assets (Liabilities), at Fair Value, Net		$ (24,100)			$ (24,100)		$ (20,600)
NEC TOKIN Corporation [Member] | Put Option [Member] | Recurring | Level 3
Schedule of Equity Method Investments [Line Items]
Change in value of NEC TOKIN option		6,900
NEC TOKIN Corporation [Member] | KEMET Electronics Corporation [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Aggregate Cost	$ 54,500
Business Acquisition, Transaction Costs	4,500
NEC TOKIN Corporation [Member] | KEMET Electronics Corporation [Member] | Stock Purchase Agreement [Member]
Schedule of Equity Method Investments [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired								51.00%
Equity Method Investment, Ownership Percentage								34.00%
Payments to Acquire Businesses, Gross	50,000
Payments to Acquire Equity Method Investments	$ 50,000
NEC TOKIN Corporation [Member] | KEMET Electronics Corporation [Member] | Stockholders Agreement [Member]
Schedule of Equity Method Investments [Line Items]
Number of Director Positions | director_position	4
NEC TOKIN Corporation [Member] | KEMET Electronics Corporation [Member] | Option Agreement [Member]
Schedule of Equity Method Investments [Line Items]
Business Acquisition Potential Future Purchase Price		$ 50,000			$ 50,000
Economic Ownership, Percentage of Ownership After Transaction				49.00%
Sale of Stock, Percentage of Ownership after Transaction				51.00%
Business Acquisition Contingent Consideration Multiple Applied to LTMEBITDA to Determine Purchase Price | number_of_times				6
NEC TOKIN Corporation [Member] | KEMET Electronics Corporation [Member] | Put Option [Member]
Schedule of Equity Method Investments [Line Items]
Business Acquisition Contingent Consideration Multiple Applied to LTMEBITDA to Determine Purchase Price | number_of_times		6			6

Investment in NEC TOKIN - Summa

Investment in NEC TOKIN - Summarized Financial Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2016
Schedule of Equity Method Investments [Line Items]
Document Period End Date			Dec. 31, 2016
NEC TOKIN Corporation [Member]
Equity Method Investment, Summarized Financial Information, Assets [Abstract]
Current assets	$ 248,128		$ 248,128		$ 240,427
Non-current assets	230,232		230,232		260,614
Equity Method Investment, Summarized Financial Information, Liabilities and Equity [Abstract]
Current liabilities	160,648		160,648		179,360
Non-current liabilities	322,768		322,768		$ 335,500
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]
Sales	127,845	$ 111,594	374,944	$ 343,686
Gross profit	28,886	24,610	82,487	74,333
Net income (loss) (1)	$ 1,082	$ (17,867)	$ 5,444	$ (10,606)

Investment in NEC TOKIN - Equit

Investment in NEC TOKIN - Equity Method Investment Income (Loss) Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Schedule of Equity Method Investments [Line Items]
Document Period End Date			Dec. 31, 2016
Income (Loss) from Equity Method Investments	$ (133)	$ (6,505)	$ 271	$ (4,758)
NEC TOKIN Corporation [Member]
Schedule of Equity Method Investments [Line Items]
Net income (loss)	$ 1,082	$ (17,867)	$ 5,444	$ (10,606)
KEC’s economic interest %	34.00%	34.00%	34.00%	34.00%
Equity Method Investment, Equity Income (Loss) Before Adjustments	$ 368	$ (6,075)	$ 1,851	$ (3,606)
Amortization and depreciation	(562)	(494)	(1,686)	(1,118)
Equity Method investment, Inventory Profit Elimination	61	64	106	(34)
Income (Loss) from Equity Method Investments	$ (133)	$ (6,505)	$ 271	$ (4,758)

Investment in NEC TOKIN - Equ41

Investment in NEC TOKIN - Equity Method Investment Reconciliation (Details) BRL in Thousands, $ in Thousands, ¥ in Millions, TWD in Millions	Jul. 26, 2016USD ($)	Jul. 26, 2016BRL	May 02, 2016USD ($)suitinstallment	Mar. 29, 2016USD ($)	Mar. 29, 2016JPY (¥)	Dec. 09, 2015USD ($)	Dec. 09, 2015TWD	Sep. 02, 2015USD ($)installment	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Mar. 31, 2016USD ($)
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity [Abstract]
Investment in NEC TOKIN									$ 21,202		$ 21,202		$ 20,334
NEC TOKIN Corporation [Member]
Related Party Transactions [Abstract]
Loss Contingency Accrual									72,500		72,500
KEMET Electronics Corporation [Member]
Related Party Transactions [Abstract]
Business Combination, Indemnification Assets, Range of Outcomes, Value, Low									8,500		8,500
Stockholders Agreement [Member] | KEMET Electronics Corporation [Member]
Related Party Transactions [Abstract]
Receivable balances									638		638		748
Equity Method Investments [Member] | Stockholders Agreement [Member]
Related Party Transactions [Abstract]
Business Combination, Indemnification Assets, Range of Outcomes, Value, Low									25,000		25,000
Indemnification Agreement [Member] | Equity Method Investments [Member]
Related Party Transactions [Abstract]
Litigation Settlement, Amount								$ (13,800)
Indemnification Agreement [Member] | Equity Method Investments [Member] | NEC TOKIN Corporation [Member]
Related Party Transactions [Abstract]
Litigation Settlement, Amount			$ (37,300)
Litigation Settlement, Number of Payment Installments | installment			5
Litigation Settlement, Number of Annual Payment Installments | installment			3
Settled Litigation [Member] | Indemnification Agreement [Member] | Equity Method Investments [Member]
Related Party Transactions [Abstract]
Litigation Settlement, Amount								$ (2,300)
Litigation Settlement, Payment Period								5 years
Litigation Settlement, Number of Payment Installments | installment								6
Preliminary Settlement [Member] | Indemnification Agreement [Member] | Equity Method Investments [Member] | NEC TOKIN Corporation [Member]
Related Party Transactions [Abstract]
Loss Contingency, Pending Claims, Number | suit			2
TAIWAN, PROVINCE OF CHINA | Taiwan, New Dollars
Related Party Transactions [Abstract]
Loss Contingency, Damages Sought, Value | TWD							TWD 1,218.2
TAIWAN, PROVINCE OF CHINA | Taiwan, New Dollars | Minimum
Related Party Transactions [Abstract]
Loss Contingency, Damages Sought, Value | TWD							TWD 609.1
TAIWAN, PROVINCE OF CHINA | United States of America, Dollars
Related Party Transactions [Abstract]
Loss Contingency, Damages Sought, Value						$ 37,700
TAIWAN, PROVINCE OF CHINA | United States of America, Dollars | Minimum
Related Party Transactions [Abstract]
Loss Contingency, Damages Sought, Value						$ 18,900
JAPAN | United States of America, Dollars
Related Party Transactions [Abstract]
Litigation Settlement, Amount				$ (1,100)
JAPAN | Japan, Yen
Related Party Transactions [Abstract]
Litigation Settlement, Amount | ¥					¥ (127.2)
BRAZIL | Settled Litigation [Member]
Related Party Transactions [Abstract]
Loss Contingency, Damages Paid, Value	$ 200	BRL 601
NEC TOKIN Corporation [Member]
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity [Abstract]
Investment in NEC TOKIN									21,202		21,202		20,334
Property, plant and equipment (1)									3,014		3,014		3,365
Technology (1)									(8,657)		(8,657)		(10,134)
Long-term debt (1)									(1,238)		(1,238)		(1,975)
Goodwill									(7,250)		(7,250)		(7,555)
Indemnity asset for legal investigation									(8,500)		(8,500)		(8,500)
Inventory profit elimination (2)									265		265		371
Other									(553)		(553)		(604)
KEC’s 34% economic interest in NEC TOKIN’s net assets									(1,717)		(1,717)		(4,698)
Related Party Transactions [Abstract]
Sales to NEC TOKIN									4,814	$ 5,020	13,096	$ 14,350
NEC TOKIN's sales to KEMET									2,350	$ 1,157	6,112	$ 4,747
Accounts receivable									2,989		2,989		5,220
Accounts payable									$ 907		$ 907		$ 1,019
KEC’s economic interest %									34.00%	34.00%	34.00%	34.00%

Segment and Geographic Inform42

Segment and Geographic Information (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 31, 2016USD ($)manufacturing_site	Sep. 30, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2016USD ($)business_groupmanufacturing_site	Dec. 31, 2015USD ($)
Segment and geographic information
Document Period End Date				Dec. 31, 2016
Number of business groups | business_group				2
Segment Reporting Information, Profit (Loss) [Abstract]
Net sales	$ 188,029		$ 177,184	$ 560,272	$ 550,897
Operating income (loss)	13,850		8,493	25,798	23,723
Depreciation and amortization expense	9,095		9,674	27,971	28,856
Restructuring charges	(369)		1,714	4,317	3,561
Write down of Long-lived Assets	0	$ 6,200	0	6,193	0
North and South America (“Americas”)
Segment Reporting Information, Profit (Loss) [Abstract]
Net sales	54,976		56,411	166,858	170,525
Europe, Middle East, Africa (“EMEA”)
Segment Reporting Information, Profit (Loss) [Abstract]
Net sales	55,765		52,453	176,298	173,468
Asia and Pacific Rim (“APAC”)
Segment Reporting Information, Profit (Loss) [Abstract]
Net sales	77,288		68,320	217,116	206,904
Operating Income (Loss) [Member]
Segment Reporting Information, Profit (Loss) [Abstract]
Restructuring charges	(369)		1,714	4,317	3,561
Write down of Long-lived Assets	0		0	6,193	0
Corporate, Non-Segment [Member]
Segment Reporting Information, Profit (Loss) [Abstract]
Operating income (loss)	(25,746)		(21,096)	(75,724)	(72,807)
Depreciation and amortization expense	1,457		1,350	4,217	3,728
Corporate, Non-Segment [Member] | Operating Income (Loss) [Member]
Segment Reporting Information, Profit (Loss) [Abstract]
Restructuring charges	2		(27)	330	481
Write down of Long-lived Assets	$ 0		0	$ 0	0
Solid Capacitors
Segment and geographic information
Number of Manufacturing Sites | manufacturing_site	9			9
Segment Reporting Information, Profit (Loss) [Abstract]
Net sales	$ 141,555		135,300	$ 426,140	416,261
Operating income (loss)	37,264		31,359	107,753	95,371
Depreciation and amortization expense	5,078		5,293	15,643	16,227
Write down of Long-lived Assets		2,100
Solid Capacitors | Operating Income (Loss) [Member]
Segment Reporting Information, Profit (Loss) [Abstract]
Restructuring charges	(128)		754	566	1,556
Write down of Long-lived Assets	$ 0		0	$ 2,076	0
Film and Electrolytic
Segment and geographic information
Number of Manufacturing Sites | manufacturing_site	9			9
Segment Reporting Information, Profit (Loss) [Abstract]
Net sales	$ 46,474		41,884	$ 134,132	134,636
Operating income (loss)	2,332		(1,770)	(6,231)	1,159
Depreciation and amortization expense	2,560		3,031	8,111	8,901
Write down of Long-lived Assets		$ 4,100
Film and Electrolytic | Operating Income (Loss) [Member]
Segment Reporting Information, Profit (Loss) [Abstract]
Restructuring charges	(243)		987	3,421	1,524
Write down of Long-lived Assets	$ 0		$ 0	$ 4,117	$ 0

Defined Benefit Pension and O43

Defined Benefit Pension and Other Postretirement Benefit Plans (Details) $ in Thousands	3 Months Ended		9 Months Ended			12 Months Ended
	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2016USD ($)plan	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Mar. 31, 2017USD ($)
Defined Benefit Plan Disclosure
Document Period End Date			Dec. 31, 2016
Pension
Defined Benefit Plan Disclosure
Contribution by employer			$ 800
Net periodic benefit (income) costs
Net service cost	$ 347	$ 404		$ 1,040	$ 1,514
Interest cost	358	338		1,076	1,013
Expected return on net assets	(94)	(105)		(283)	(315)
Amortization:
Defined Benefit Plan, Actuarial Gain (Loss)	115	197		345	591
Prior service cost	21	15		64	44
Total net periodic benefit (income) costs	747	849		2,242	2,847
Pension | Europe
Defined Benefit Plan Disclosure
Defined Benefit Plan, Number of Plans | plan			6
Pension | Singapore
Defined Benefit Plan Disclosure
Defined Benefit Plan, Number of Plans | plan			1
Pension | Mexico
Defined Benefit Plan Disclosure
Defined Benefit Plan, Number of Plans | plan			2
Post-retirement Benefit Plan
Net periodic benefit (income) costs
Net service cost	0	0		0	0
Interest cost	1	3		9	14
Expected return on net assets	0	0		0	0
Amortization:
Defined Benefit Plan, Actuarial Gain (Loss)	(71)	(64)		(155)	(143)
Prior service cost	0	0		0	0
Total net periodic benefit (income) costs	$ (70)	$ (61)		$ (146)	$ (129)
Subsequent Event [Member] | Pension | Maximum
Defined Benefit Plan Disclosure
Estimated employer contribution in current fiscal year						$ 1,700

Stock-based Compensation - Narr

Stock-based Compensation - Narrative (Details) - shares	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	7,400,000
Stock options exercised	15,500	0
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period	10 years
Employee Stock Option [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	2 years
Employee Stock Option [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Restricted Stock Units (RSUs) [Member] | Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Period of restriction for sale of shares	90 days
Restricted Stock Units (RSUs) [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Restricted Stock Units (RSUs) [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
Omnibus Equity Incentive Plan 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	6,600,000
Prior Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	800,000
Long Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period	P2Y
Long Term Incentive Plan 2017 2018 [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Long Term Incentive Plan 2016 2017 [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Long Term Incentive Plan 2015 2016 [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Long Term Incentive Plan 2014 2015 [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Long Term Incentive Plan 2013 2014 [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years

Stock-based Compensation - Sche

Stock-based Compensation - Schedule of Award Activity (Details) - $ / shares shares in Thousands	May 18, 2016	Dec. 31, 2016
Restricted Stock Units (RSUs) [Member] | Long Term Incentive Plan 2017 2018 [Member]
Shares
Granted	613
Weighted- average Fair Value on Grant Date
Granted		$ 2.46
Restricted Stock Units (RSUs) [Member] | May 18, 2017 | Long Term Incentive Plan 2017 2018 [Member]
Shares
Granted	202
Restricted Stock Units (RSUs) [Member] | May 18, 2018 | Long Term Incentive Plan 2017 2018 [Member]
Shares
Granted	202
Restricted Stock Units (RSUs) [Member] | May 18, 2019 | Long Term Incentive Plan 2017 2018 [Member]
Shares
Granted	209
Restricted Stock Units, Time-Based Award [Member] | Long Term Incentive Plan 2016 2017 [Member]
Shares
Vested		(187)
Restricted Stock Units, Time-Based Award [Member] | Long Term Incentive Plan 2015 2016 [Member]
Shares
Vested		(111)
Restricted Stock Units, Time-Based Award [Member] | Long Term Incentive Plan 2014 2015 [Member]
Shares
Vested		(130)
Restricted Stock Units, Performance-Based Award [Member] | Long Term Incentive Plan 2016 2017 [Member]
Shares
Vested		0
Restricted Stock Units, Performance-Based Award [Member] | Long Term Incentive Plan 2015 2016 [Member]
Shares
Vested		(103)
Restricted Stock Units, Performance-Based Award [Member] | Long Term Incentive Plan 2014 2015 [Member]
Shares
Vested		(73)
Restricted Stock
Shares
Beginning balance		1,430
Granted		381
Vested		(328)
Forfeited		(20)
Ending balance		1,463
Weighted- average Fair Value on Grant Date
Beginning balance		$ 3.51
Granted		4.82
Vested		3.06
Forfeited		3.19
Ending balance		$ 5.21

Stock-based Compensation - Allo

Stock-based Compensation - Allocation of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Document Period End Date			Dec. 31, 2016
Long Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	$ 621	$ 655	$ 1,927	$ 2,112
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	7	23	42	155
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	511	476	1,502	1,494
Cost of Sales [Member] | Long Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	178	127	557	624
Cost of Sales [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	3	11	21	72
Cost of Sales [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	127	130	415	444
Selling, General and Administrative Expenses [Member] | Long Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	402	474	1,232	1,365
Selling, General and Administrative Expenses [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	4	11	20	79
Selling, General and Administrative Expenses [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	379	340	1,072	1,033
Research and Development Expense [Member] | Long Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	41	54	138	123
Research and Development Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	0	1	1	4
Research and Development Expense [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	$ 5	$ 6	$ 15	$ 17

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Income Tax Contingency [Line Items]
Document Period End Date			Dec. 31, 2016
Current Income Tax Expense (Benefit)	$ 1,800,000
Income tax expense (benefit)	1,810,000	$ 2,760,000	$ 4,440,000	$ 3,950,000
Current Federal Tax Expense (Benefit)	0	$ 0	0	0
Foreign Tax Authority [Member]
Income Tax Contingency [Line Items]
Income tax expense (benefit)	1,700,000		4,300,000	4,400,000
State and Local Jurisdiction [Member]
Income Tax Contingency [Line Items]
Income tax expense (benefit)	$ 100,000		$ 100,000	200,000
Intellidata [Member]
Income Tax Contingency [Line Items]
Current Income Tax Expense (Benefit)				$ (600,000)

Basic and Diluted Net Income 48

Basic and Diluted Net Income (Loss) Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Numerator:
Net income (loss)	$ 12,278	$ (8,600)	$ (4,925)	$ (38,456)
Weighted-average shares outstanding:
Basic (in shares)	46,606	46,081	46,469	45,953
Assumed conversion of employee stock grants (in shares)	2,122	0	0	0
Assumed conversion of warrants (in shares)	6,568	0	0	0
Diluted (in shares)	55,296	46,081	46,469	45,953
Net income (loss) per basic share (in usd per share)	$ 0.26	$ (0.19)	$ (0.11)	$ (0.84)
Net income (loss) per diluted share (in usd per share)	$ 0.22	$ (0.19)	$ (0.11)	$ (0.84)
Common stock equivalents that could potentially dilute net income per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been antidilutive
Document Period End Date			Dec. 31, 2016
Common stock equivalents (in shares)	800	3,257	2,760	3,247
Assumed conversion of warrants
Common stock equivalents that could potentially dilute net income per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been antidilutive
Common stock equivalents (in shares)	0	5,168	5,913	5,261

Derivatives Fair Value (Details

Derivatives Fair Value (Details) $ in Thousands	3 Months Ended	9 Months Ended
	Dec. 31, 2016USD ($)	Dec. 31, 2016USD ($)
Foreign Exchange Forward [Member] | Prepaid Expenses and Other Current Assets [Member]
Derivative Instrument Detail [Abstract]
Derivative Asset, Fair Value, Gross Asset	$ 0	$ 0
Foreign Exchange Forward [Member] | Accrued Liabilities [Member]
Derivative Instrument Detail [Abstract]
Derivative Liability, Fair Value, Gross Liability	3,240	3,240
Mexico, Pesos
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	47,500	47,500
Sales [Member]
Derivative Instrument Detail [Abstract]
Derivative, Gain (Loss) on Derivative, Net	0	0
Cost of sales
Derivative Instrument Detail [Abstract]
Derivative, Gain (Loss) on Derivative, Net	(980)	(3,873)
Operating Expense [Member]
Derivative Instrument Detail [Abstract]
Derivative, Gain (Loss) on Derivative, Net	(980)	(3,873)
Operating Income (Loss) [Member]
Derivative Instrument Detail [Abstract]
Derivative, Gain (Loss) on Derivative, Net	$ (980)	$ (3,873)

Concentrations of Risks (Detail

Concentrations of Risks (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2016
Net revenue | Sales risk
Concentration of Risk
Concentration Risk, Customer	1	1	1	1
Net revenue | Sales risk | Minimum
Concentration of Risk
Concentration risk, percentage	10.00%	10.00%	10.00%	10.00%
Net revenue | Electronics distributor risk
Concentration of Risk
Concentration risk, percentage			46.00%	41.00%
Accounts receivable | Sales risk
Concentration of Risk
Concentration Risk, Customer	0	0	0
Accounts receivable | Sales risk | Maximum
Concentration of Risk
Concentration risk, percentage					10.00%
Accounts receivable | Credit Concentration Risk [Member]
Concentration of Risk
Concentration Risk, Customer				0
Accounts receivable | Credit Concentration Risk [Member] | Maximum
Concentration of Risk
Concentration risk, percentage			10.00%

Condensed Consolidating Finan51

Condensed Consolidating Financial Statements Balance Sheet (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015	Mar. 31, 2015
Current assets:
Cash and cash equivalents	$ 87,356	$ 65,004	$ 43,158	$ 56,362
Accounts receivable, net	82,519	93,168
Intercompany receivable	0	0
Inventories, net	154,519	168,879
Prepaid expenses and other	24,035	25,496
Total current assets	348,429	352,547
Assets, Noncurrent [Abstract]
Property and equipment, net	211,927	241,839
Goodwill	40,294	40,294
Intangible assets, net	30,204	33,301
Investment in NEC TOKIN	21,202	20,334
Investments in subsidiaries	0	0
Deferred income taxes	7,768	8,397
Other assets	2,712	3,068
Long-term intercompany receivable	0	0
Total assets	662,536	699,780
Current liabilities:
Current portion of long-term debt	0	2,000
Accounts payable	62,347	70,981
Intercompany payable	0	0
Accrued expenses	46,418	50,320
Income taxes payable	1,068	453
Total current liabilities	109,833	123,754
Liabilities, Noncurrent [Abstract]
Long-term debt, less current portion	386,226	385,833
Other non-current obligations	72,704	74,892
Deferred income taxes	3,326	2,820
Long-term intercompany payable	0	0
Stockholders’ equity	90,447	112,481
Total liabilities and stockholders’ equity	662,536	699,780
Reclassifications and Eliminations
Current assets:
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Intercompany receivable	(377,917)	(332,957)
Inventories, net	0	0
Prepaid expenses and other	(2,964)	(2,964)
Total current assets	(380,881)	(335,921)
Assets, Noncurrent [Abstract]
Property and equipment, net	0	0
Goodwill	0	0
Intangible assets, net	0	0
Investment in NEC TOKIN	0	0
Investments in subsidiaries	(915,622)	(905,190)
Deferred income taxes	0	0
Other assets	0	0
Long-term intercompany receivable	(101,941)	(110,016)
Total assets	(1,398,444)	(1,351,127)
Current liabilities:
Current portion of long-term debt		0
Accounts payable	0	0
Intercompany payable	(377,917)	(332,957)
Accrued expenses	0	0
Income taxes payable	(2,964)	(2,964)
Total current liabilities	(380,881)	(335,921)
Liabilities, Noncurrent [Abstract]
Long-term debt, less current portion	0	0
Other non-current obligations	0	0
Deferred income taxes	0	0
Long-term intercompany payable	(101,941)	(110,016)
Stockholders’ equity	(915,622)	(905,190)
Total liabilities and stockholders’ equity	(1,398,444)	(1,351,127)
Parent
Current assets:
Cash and cash equivalents	729	640	640	640
Accounts receivable, net	0	0
Intercompany receivable	32,874	30,210
Inventories, net	0	0
Prepaid expenses and other	3,325	3,325
Total current assets	36,928	34,175
Assets, Noncurrent [Abstract]
Property and equipment, net	498	255
Goodwill	0	0
Intangible assets, net	0	0
Investment in NEC TOKIN	0	0
Investments in subsidiaries	394,561	382,108
Deferred income taxes	0	0
Other assets	27	0
Long-term intercompany receivable	62,496	67,500
Total assets	494,510	484,038
Current liabilities:
Current portion of long-term debt		2,000
Accounts payable	40	20
Intercompany payable	42,935	280
Accrued expenses	8,743	17,305
Income taxes payable	0	0
Total current liabilities	51,718	19,605
Liabilities, Noncurrent [Abstract]
Long-term debt, less current portion	352,345	351,952
Other non-current obligations	0	0
Deferred income taxes	0	0
Long-term intercompany payable	0	0
Stockholders’ equity	90,447	112,481
Total liabilities and stockholders’ equity	494,510	484,038
Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	46,038	36,209	18,643	33,094
Accounts receivable, net	26,500	41,025
Intercompany receivable	195,280	132,523
Inventories, net	102,559	113,289
Prepaid expenses and other	11,976	12,161
Total current assets	382,353	335,207
Assets, Noncurrent [Abstract]
Property and equipment, net	81,692	93,936
Goodwill	40,294	40,294
Intangible assets, net	25,020	27,252
Investment in NEC TOKIN	21,202	20,334
Investments in subsidiaries	427,702	429,723
Deferred income taxes	1,045	800
Other assets	1,779	2,452
Long-term intercompany receivable	38,356	41,428
Total assets	1,019,443	991,426
Current liabilities:
Current portion of long-term debt		0
Accounts payable	30,601	34,618
Intercompany payable	270,738	275,498
Accrued expenses	19,334	11,807
Income taxes payable	3,007	2,983
Total current liabilities	323,680	324,906
Liabilities, Noncurrent [Abstract]
Long-term debt, less current portion	19,881	19,881
Other non-current obligations	27,399	25,797
Deferred income taxes	2,556	2,242
Long-term intercompany payable	62,496	67,500
Stockholders’ equity	583,431	551,100
Total liabilities and stockholders’ equity	$ 1,019,443	991,426
Guarantor Subsidiaries | Reportable legal entities
Condensed Consolidating Balance Sheet
Percentage of ownership interest	100.00%
Non-Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	$ 40,589	28,155	$ 23,875	$ 22,628
Accounts receivable, net	56,019	52,143
Intercompany receivable	149,763	170,224
Inventories, net	51,960	55,590
Prepaid expenses and other	11,698	12,974
Total current assets	310,029	319,086
Assets, Noncurrent [Abstract]
Property and equipment, net	129,737	147,648
Goodwill	0	0
Intangible assets, net	5,184	6,049
Investment in NEC TOKIN	0	0
Investments in subsidiaries	93,359	93,359
Deferred income taxes	6,723	7,597
Other assets	906	616
Long-term intercompany receivable	1,089	1,088
Total assets	547,027	575,443
Current liabilities:
Current portion of long-term debt		0
Accounts payable	31,706	36,343
Intercompany payable	64,244	57,179
Accrued expenses	18,341	21,208
Income taxes payable	1,025	434
Total current liabilities	115,316	115,164
Liabilities, Noncurrent [Abstract]
Long-term debt, less current portion	14,000	14,000
Other non-current obligations	45,305	49,095
Deferred income taxes	770	578
Long-term intercompany payable	39,445	42,516
Stockholders’ equity	332,191	354,090
Total liabilities and stockholders’ equity	$ 547,027	$ 575,443
10.5% Senior Notes, net [Member]
Condensed Consolidating Balance Sheet
Interest rate of senior notes (as a percent)	10.50%
10.5% Senior Notes, net [Member] | Non-Guarantor Subsidiaries
Condensed Consolidating Balance Sheet
Percentage of capital stock	51.00%

Condensed Consolidating Finan52

Condensed Consolidating Financial Statements Income Statement (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Revenues [Abstract]
Net sales	$ 188,029		$ 177,184	$ 560,272	$ 550,897
Operating costs and expenses:
Cost of sales	140,692		138,436	423,999	429,630
Selling, general and administrative expenses	26,665		22,278	78,551	75,656
Research and development	7,059		6,134	21,107	18,560
Restructuring charges	(369)		1,714	4,317	3,561
Write down of long-lived assets	0	$ 6,200	0	6,193	0
Net (gain) loss on sales and disposals of assets	132		129	307	(233)
Total operating costs and expenses	174,179		168,691	534,474	527,174
Operating income (loss)	13,850		8,493	25,798	23,723
Interest income	(5)		(4)	(14)	(10)
Interest expense	9,918		9,852	29,751	29,676
Change in value of NEC TOKIN option	(6,900)		(700)	3,500	26,300
Other (income) expense, net	3,384		1,320	6,683	2,495
Equity in earnings of subsidiaries	0		0	0	0
Income (loss) from before income taxes and equity income (loss) from NEC TOKIN	14,221		665	(756)	(29,748)
Income tax expense (benefit)	1,810		2,760	4,440	3,950
Income (loss) before equity income (loss) from NEC TOKIN	12,411		(2,095)	(5,196)	(33,698)
Equity income (loss) from NEC TOKIN	(133)		(6,505)	271	(4,758)
Net income (loss)	12,278		(8,600)	(4,925)	(38,456)
Reclassifications and Eliminations
Revenues [Abstract]
Net sales	(203,106)		(204,615)	(601,795)	(632,515)
Operating costs and expenses:
Cost of sales	(189,691)		(191,833)	(562,337)	(590,274)
Selling, general and administrative expenses	(13,415)		(12,782)	(39,459)	(42,241)
Research and development	0		0	0	0
Restructuring charges	0		0	0	0
Write down of long-lived assets	0			0
Net (gain) loss on sales and disposals of assets	0		0	0	0
Total operating costs and expenses	(203,106)		(204,615)	(601,796)	(632,515)
Operating income (loss)	0		0	1	0
Interest income	0		0	0	0
Interest expense	0		0	0	0
Change in value of NEC TOKIN option	0		0	0	0
Other (income) expense, net	0		0	0	0
Equity in earnings of subsidiaries	(23,211)		(1,547)	(27,047)	7,567
Income (loss) from before income taxes and equity income (loss) from NEC TOKIN	(23,211)		(1,547)	(27,046)	7,567
Income tax expense (benefit)	0		0	0	0
Income (loss) before equity income (loss) from NEC TOKIN	(23,211)		(1,547)	(27,046)	7,567
Equity income (loss) from NEC TOKIN	0		0	0	0
Net income (loss)	(23,211)		(1,547)	(27,046)	7,567
Parent
Revenues [Abstract]
Net sales	0		0	0	0
Operating costs and expenses:
Cost of sales	257		232	1,023	931
Selling, general and administrative expenses	11,695		8,306	31,471	27,028
Research and development	72		79	228	26
Restructuring charges	0		0	0	0
Write down of long-lived assets	0			0
Net (gain) loss on sales and disposals of assets	(7)		0	(292)	(7)
Total operating costs and expenses	12,017		8,617	32,430	27,978
Operating income (loss)	(12,017)		(8,617)	(32,430)	(27,978)
Interest income	0		0	0	0
Interest expense	9,395		9,461	28,214	28,395
Change in value of NEC TOKIN option	0		0	0	0
Other (income) expense, net	10,479		7,931	28,672	25,484
Equity in earnings of subsidiaries	23,211		1,547	27,047	(7,567)
Income (loss) from before income taxes and equity income (loss) from NEC TOKIN	12,278		(8,600)	(4,925)	(38,456)
Income tax expense (benefit)	0		0	0	0
Income (loss) before equity income (loss) from NEC TOKIN	12,278		(8,600)	(4,925)	(38,456)
Equity income (loss) from NEC TOKIN	0		0	0	0
Net income (loss)	12,278		(8,600)	(4,925)	(38,456)
Guarantor Subsidiaries
Revenues [Abstract]
Net sales	211,214		211,268	642,253	655,808
Operating costs and expenses:
Cost of sales	163,260		173,368	499,922	528,352
Selling, general and administrative expenses	16,590		16,207	52,796	56,197
Research and development	4,708		4,232	13,581	12,834
Restructuring charges	(466)		726	3,125	2,182
Write down of long-lived assets	(1,608)			4,585
Net (gain) loss on sales and disposals of assets	109		(348)	1,132	(1,101)
Total operating costs and expenses	182,593		194,185	575,141	598,464
Operating income (loss)	28,621		17,083	67,112	57,344
Interest income	0		0	3	0
Interest expense	383		267	1,161	865
Change in value of NEC TOKIN option	(6,900)		(700)	3,500	26,300
Other (income) expense, net	(11,671)		(7,997)	(29,556)	(25,065)
Equity in earnings of subsidiaries	0		0	0	0
Income (loss) from before income taxes and equity income (loss) from NEC TOKIN	23,467		9,519	32,892	5,114
Income tax expense (benefit)	37		44	94	(320)
Income (loss) before equity income (loss) from NEC TOKIN	23,430		9,475	32,798	5,434
Equity income (loss) from NEC TOKIN	(133)		(6,505)	271	(4,758)
Net income (loss)	23,297		2,970	33,069	676
Non-Guarantor Subsidiaries
Revenues [Abstract]
Net sales	179,921		170,531	519,814	527,604
Operating costs and expenses:
Cost of sales	166,866		156,669	485,391	490,621
Selling, general and administrative expenses	11,795		10,547	33,743	34,672
Research and development	2,279		1,823	7,298	5,700
Restructuring charges	97		988	1,192	1,379
Write down of long-lived assets	1,608			1,608
Net (gain) loss on sales and disposals of assets	30		477	(533)	875
Total operating costs and expenses	182,675		170,504	528,699	533,247
Operating income (loss)	(2,754)		27	(8,885)	(5,643)
Interest income	(5)		(4)	(17)	(10)
Interest expense	140		124	376	416
Change in value of NEC TOKIN option	0		0	0	0
Other (income) expense, net	4,576		1,386	7,567	2,076
Equity in earnings of subsidiaries	0		0	0	0
Income (loss) from before income taxes and equity income (loss) from NEC TOKIN	1,687		1,293	(1,677)	(3,973)
Income tax expense (benefit)	1,773		2,716	4,346	4,270
Income (loss) before equity income (loss) from NEC TOKIN	(86)		(1,423)	(6,023)	(8,243)
Equity income (loss) from NEC TOKIN	0		0	0	0
Net income (loss)	$ (86)		$ (1,423)	$ (6,023)	$ (8,243)

Condensed Consolidating Finan53

Condensed Consolidating Financial Statements Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Condensed Consolidated Statements of Comprehensive Income (Loss)
Comprehensive income (loss)	$ 6,781	$ (6,900)	$ (24,524)	$ (43,347)
Reclassifications and Eliminations
Condensed Consolidated Statements of Comprehensive Income (Loss)
Comprehensive income (loss)	(23,211)	(1,547)	(27,046)	7,567
Parent
Condensed Consolidated Statements of Comprehensive Income (Loss)
Comprehensive income (loss)	8,602	(10,474)	(9,929)	(37,698)
Guarantor Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (Loss)
Comprehensive income (loss)	29,828	4,604	32,331	(7,109)
Non-Guarantor Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (Loss)
Comprehensive income (loss)	$ (8,438)	$ 517	$ (19,880)	$ (6,107)

Condensed Consolidating Finan54

Condensed Consolidating Financial Statements Cash Flow (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Operating Activities:
Net cash provided by (used in) operating activities	$ 42,144	$ (557)
Investing activities:
Capital expenditures	(15,011)	(14,120)
Proceeds from sale of assets	0	898
Acquisitions, net of cash received	0	(2,892)
Net cash provided by (used in) investing activities	(15,011)	(16,114)
Financing activities:
Proceeds from revolving line of credit	0	10,000
Payments of revolving line of credit	0	(5,500)
Payments on long-term obligations	(2,428)	(481)
Proceeds from exercise of stock options	69
Purchase of treasury stock	(1,052)	(691)
Net cash provided by (used in) financing activities	(3,411)	3,328
Net increase (decrease) in cash and cash equivalents	23,722	(13,343)
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]
Effect of foreign currency fluctuations on cash	(1,370)	139
Cash and cash equivalents at beginning of fiscal period	65,004	56,362
Cash and cash equivalents at end of fiscal period	87,356	43,158
Reclassifications and Eliminations
Operating Activities:
Net cash provided by (used in) operating activities	0	0
Investing activities:
Capital expenditures	0	0
Proceeds from sale of assets		0
Acquisitions, net of cash received		0
Net cash provided by (used in) investing activities	0	0
Financing activities:
Proceeds from revolving line of credit		0
Payments of revolving line of credit		0
Payments on long-term obligations	0	0
Proceeds from exercise of stock options	0
Purchase of treasury stock	0	0
Net cash provided by (used in) financing activities	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]
Effect of foreign currency fluctuations on cash	0	0
Cash and cash equivalents at beginning of fiscal period	0	0
Cash and cash equivalents at end of fiscal period	0	0
Parent
Operating Activities:
Net cash provided by (used in) operating activities	2,942	691
Investing activities:
Capital expenditures	0	0
Proceeds from sale of assets		0
Acquisitions, net of cash received		0
Net cash provided by (used in) investing activities	0	0
Financing activities:
Proceeds from revolving line of credit		0
Payments of revolving line of credit		0
Payments on long-term obligations	(1,870)	0
Proceeds from exercise of stock options	69
Purchase of treasury stock	(1,052)	(691)
Net cash provided by (used in) financing activities	(2,853)	(691)
Net increase (decrease) in cash and cash equivalents	89	0
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]
Effect of foreign currency fluctuations on cash	0	0
Cash and cash equivalents at beginning of fiscal period	640	640
Cash and cash equivalents at end of fiscal period	729	640
Guarantor Subsidiaries
Operating Activities:
Net cash provided by (used in) operating activities	14,962	(8,085)
Investing activities:
Capital expenditures	(5,133)	(6,221)
Proceeds from sale of assets		247
Acquisitions, net of cash received		(2,892)
Net cash provided by (used in) investing activities	(5,133)	(8,866)
Financing activities:
Proceeds from revolving line of credit		8,000
Payments of revolving line of credit		(5,500)
Payments on long-term obligations	0	0
Proceeds from exercise of stock options	0
Purchase of treasury stock	0	0
Net cash provided by (used in) financing activities	0	2,500
Net increase (decrease) in cash and cash equivalents	9,829	(14,451)
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]
Effect of foreign currency fluctuations on cash	0	0
Cash and cash equivalents at beginning of fiscal period	36,209	33,094
Cash and cash equivalents at end of fiscal period	46,038	18,643
Non-Guarantor Subsidiaries
Operating Activities:
Net cash provided by (used in) operating activities	24,240	6,837
Investing activities:
Capital expenditures	(9,878)	(7,899)
Proceeds from sale of assets		651
Acquisitions, net of cash received		0
Net cash provided by (used in) investing activities	(9,878)	(7,248)
Financing activities:
Proceeds from revolving line of credit		2,000
Payments of revolving line of credit		0
Payments on long-term obligations	(558)	(481)
Proceeds from exercise of stock options	0
Purchase of treasury stock	0	0
Net cash provided by (used in) financing activities	(558)	1,519
Net increase (decrease) in cash and cash equivalents	13,804	1,108
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]
Effect of foreign currency fluctuations on cash	(1,370)	139
Cash and cash equivalents at beginning of fiscal period	28,155	22,628
Cash and cash equivalents at end of fiscal period	$ 40,589	$ 23,875